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Lactating dairy cows have a high demand for glucose to synthesize milk lactose 
(BICKERSTAFF et al. 1974; RIGOUT et al. 2002b). However, little glucose is available for 
absorption from normal diets since the majority of ingested carbohydrates are converted to 
short chain fatty acids (SCFA) in the rumen (e.g., to acetate, propionate and butyrate; 
REYNOLDS et al. 1994). As an alternative source, endogenous glucose production through 
hepatic gluconeogenesis is considered to supply most of the glucose in dairy cows (YOUNG 
1977). It has been estimated that 90% of the circulating glucose (~3kg/d) originates from this 
process (YOUNG 1977; REYNOLDS et al. 1988), and 60-80% from this amount are utilized 
for milk lactose synthesis (BICKERSTAFF et al. 1974). Given the high glucose requirements, 
limitations in glucose availability play a crucial role in the development of metabolic (BOBE 
et al. 2004) and reproductive disorders (BUTLER 2000; MARTENS 2007) in high-yielding 
cows. Therefore, much effort has focussed recently on measures to increase the direct 
absorption of glucose from the intestine via postruminally digestible starch, which is 
energetically more efficient than hepatic glucose synthesis (OWENS et al. 1986). 
 
With the intention to address the consequences of additional glucose supply, numerous 
studies investigated the effects of different levels of intravenous (AMARAL et al. 1990; KIM 
et al. 2000) or postruminal glucose infusions (RIGOUT et al. 2002a,b) on lactation 
performance and/or on tissues intermediary metabolism (e.g. glucose and lipid metabolism). 
Although the effects of glucose supply on milk yield have been studied thoroughly, the 
beneficial effect of surplus glucose on lactation performance is still a subject of continuing 
research and debate. Some studies have demonstrated that milk yield increased with glucose 
infusion (FROBISH and DAVIS 1977; RIGOUT et al. 2002b), whereas others have shown no 
change (AMARAL et al. 1990; HURTAUD et al. 1998). Reasons for the inconsistent effect of 
postruminal glucose supply on milk yield may lie in the infusion dose as suggested by 
RIGOUT et al. (2002b). In their study, moderate doses of duodenal glucose infusion 
improved net mammary balance of glucose and, in turn, increased lactose synthesis and milk 
output. In contrast, excessive glucose supply impaired the intracellular glucose metabolism 
which negatively affected milk lactose synthesis and milk yield. However, it is still an open 
question whether the dose effects on lactation performance observed by RIGOUT et al. 
(2002b) after postruminal application of glucose were primarily caused by increased glucose 
availability for the mammary gland. An alternative explanation could be that postruminal 





peptide-1) that affected intermediary glucose metabolism and feed intake (HOLST 2007). 
Therefore, the first goal of the present study was to test whether intravenously applied glucose 
elicits dose effects on lactation performance that are similar to those observed previously after 
gastrointestinal glucose supply (see chapter 3). 
 
Amongst the metabolic adaptations that underlie the effects of glucose supply on 
performance, hepatic gluconeogenesis is of particular interest. The observed decreases in the 
rate of hepatic glucose production during surplus glucose supply (BARTLEY and BLACK 
1966; THOMPSON et al. 1975) might explain the limited or missing effects of surplus 
glucose on milk yield in certain studies. However, only a few experiments investigated 
whether the decrease in hepatic gluconeogenesis might be caused by changes in hepatic 
gluconeogenesis enzymes catalytic capacity. One previous study showed a decrease in the 
activities of five gluconeogenic enzymes by extreme overfeeding prepartum (MURONDOTI 
et al. 2004) while another study showed a decrease in the activity of hepatic glucose 6-
phospatase (G6-Pase, EC 3.1.3.9) by high doses of glucose infused intraduodenally 
(BARTLEY et al. 1966). So far, no data are available about the dose-dependent adaptive 
responses of hepatic gluconeogenesis enzymes activity and gene expression levels to glucose 
supply in dairy cows. Accordingly, the second goal of the present study was to examine the 
dose effects of surplus glucose on the activities and gene expression levels of four rate-
limiting gluconeogenesis enzymes (see chapter 4). 
 
In non-ruminants, one adverse consequence of prolonged increases in systemic glucose 
availability is the development of insulin resistance (DOBBINS et al. 2001; CAHOVÁ et al. 
2007). It has been shown that decreases in the skeletal muscle activity of carnitine 
palmitoyltransferases, (CPT, EC 2.3.1.21), the rate limiting enzyme in the β-oxidation of fatty 
acids, play a crucial role in this process (i.e. lipotoxicity theory, KREBS and RODEN 2004; 
CAHOVÁ et al. 2007). HOLTENIUS et al. (2003) reported that overconsumption of energy 
during the dry period was associated with the development of peripheral insulin resistance in 
dairy cows, too. In dairy cows, this peripheral insulin resistance could be related to 
adaptations of hepatic CPT activity to changing energy supply (AIELLO et al. 1984; DANN 
and DRACKLEY 2005) but a similar responsiveness of CPT in muscle tissue has never been 
thoroughly investigated. Therefore, the last goal of the present study was to test whether the 
development of peripheral insulin resistance in dairy cows may be linked to inadequate 





2   Literature Review 
2.1 Glucose Requirement and Partitioning in Dairy Cows 
Dairy cows have a requirement for glucose as a primary metabolic fuel for many tissues. In 
the non-pregnant, non-lactating cow, about 200 g/day of glucose is estimated for non-
mammary tissues maintenance (REYNOLDS 2005), while during late pregnancy, the gravid 
uterus consumes approximately half (~650 g/d) of the maternal glucose blood supply for fetal 
oxidative metabolism (BELL 1995). Nonetheless, previous studies have shown that 60 to 85% 
of the total glucose used in lactating dairy cows is utilized by the mammary gland 
(BICKERSTAFF et al. 1974). Using the following formula which calculated the daily 
turnover of glucose in lactating dairy cows: Y = 1.64 + 0.396x (where Y = daily glucose 
turnover Mol/d; x = daily milk production kg/d; DANFÆR 1994),  MARTENS (2007) 
estimated that ~3.1 kg/d of glucose is required for a cow to produce 40 litres of milk per day. 
The dependence of mammary secretion on glucose supply is almost certainly due to the role 
of glucose as a precursor of milk lactose synthesis which accounts for 50 to 85% of the total 
glucose extracted by the mammary gland (ANNISON et al. 1974; BICKERSTAFF et al. 
1974).  
 
In addition to the mammary gland, the portal-drained viscera (PDV) are also net 
consumers of glucose in ruminants, even in situations when postruminal starch delivers 
moderate amounts of additional glucose for direct absorption from the intestine (REYNOLDS 
et al. 1994; FREETLY and KLINDT 1996). Glucose further constitutes an essential 
metabolite for the brain with approximately 10 – 15% of whole-body glucose utilization 
(LINDSAY 1979; ORTIGUES-MARTY et al. 2003). Glucose consumption by skeletal 
muscle depends on both glucose availability and physical activity. Glucose may be oxidized 
in the muscle cells to CO2 which accounts for ~30 - 60 % of total CO2 produced by the 
muscle or it may be stored as glycogen (HOCQUETTE et al. 1998). The oxidization of 
glucose in muscle cells and many other cells of the body generates adenosine triphosphate 
(ATP) as an universal fuel for energy-dependent processes, while some tissues additionally 
use intermediates of glycolysis for synthesis pathways (e.g. glycerol for the production of 









2.2 Glucose Metabolism in Ruminants 
As in monogastric animals, glucose is the main energy source for several metabolic processes 
in ruminants; however, there are great differences regarding to the source and metabolism of 
glucose between the two groups of species. Absorption of glucose in the small intestine 
constitutes the major source for glucose supply in monogastric animals (GRAY 1992). In 
contrast, only little glucose is available for absorption in the small intestine of ruminants 
under many dietary regimes as most of the ingested carbohydrates are microbially fermented 
to SCFA in the rumen (YOUNG 1977; REYNOLDS et al. 1994). These SCFA may supply 
70-80% of the daily energy requirements to the animal (BERGMAN 1990). Ruminants have 
adapted to the limited availability of glucose by high rates of hepatic gluconeogenesis, by the 
limited use of glucose for oxidation, and by the primary use of acetate instead of glucose for 
fatty acid synthesis (BROCKMAN and LAARVELD 1986; DANFÆR et al. 1995). To ensure 
that the liver fulfils its role as an organ of net glucose production, ruminant hepatocytes lack 
measurable glucokinase activity to counteract glucose uptake and utilization by the liver 
(BALLARD et al. 1969). 
 
2.2.1 Hormonal Control of Glucose Metabolism 
Insulin and glucagon are the major hormones regulating glucose metabolism in ruminants, 
just as they are in monogastric species (MCDOWELL 1983). Insulin controls a variety of 
cellular glucose homeostasis processes, the most important being the stimulation of glucose 
uptake into certain cell types. Most mammalian cells take up glucose by facilitated diffusion 
via tissue-specific glucose transporter (GLUT) proteins (BELL et al. 1990). These 
transporters are divided into insulin-sensitive (e.g., GLUT-4) and non insulin-sensitive 
glucose transporters (e.g., GLUT-1, 2, 3 and 5) in both monogastric animals (BELL et al. 
1990) and ruminants (HOCQUETTE and ABE 2000). The insulin-sensitive transporter, 
GLUT-4, is found mainly in adipose and skeletal muscle tissues both in ruminants (ZHAO et 
al. 1993; ABE et al. 1997) and in monogastric species (BELL et al. 1990).  
 
While insulin is a central hormone in the regulation of glucose metabolism in all 
mammalian species, insulin sensitivity of whole body glucose utilization differs greatly 
between ruminants and monogastric species. Application of the hyperinsulinemic, euglycemic 
clamp technique has demonstrated that ruminants are generally less sensitive to insulin 
compared with monogastric animals (KASEK et al. 2001; SASAKI 2002). The lower insulin-





glucose uptake rates in ruminants (JANES et al. 1985b; ROSE et al. 1998). In lactating dairy 
cows, it has been estimated that about 80 % of the cellular glucose uptake occurs independent 
of insulin (ROSE et al. 1998). One major GLUT mediating insulin-independent glucose 
uptake is GLUT-1 which is expressed in many tissues including the brain, kidney and 
mammary gland (ZHAO et al. 1993; KOMATSU et al. 2005). In contrast to monogastric 
species, GLUT-1 is also highly prevalent in adult bovine glycolytic muscles and adipose 
tissue, which can explain their capability and high degree of insulin-independent glucose 
uptake (ABE et al. 2001; DUHLMEIER et al. 2005). Since GLUT-1 and GLUT-4 have 
comparable affinity for glucose (Km = 5 mM for both transporter; BELL et al.1993), the ratio 
of their membrane expression relates directly to the insulin-sensitivity of glucose uptake. 
 
Another important difference between ruminant and monogastric animals is the low 
correlation between plasma glucose and insulin concentrations (MCATEE and TRENKLE 
1971). Although intravenous (THOMPOSON et al. 1975; AMARAL et al. 1990; 
GRÜNBERG et al. 2006) and duodenal (LEMOSQUET et al. 1997) infusions of glucose can 
increase blood insulin concentrations in dairy cows, some studies showed little effect of 
glucose infusion on circulating insulin concentrations, especially, in lactating cows 
(FROBISH and DAVIS 1976; LOMAX et al. 1979). Moreover, higher plasma levels of 
insulin were observed after the intravenous infusion of propionate compared to glucose, 
suggesting that ruminants are more sensitive to propionate as a stimulator of insulin release 
than to glucose (MCATEE and TRENKLE 1971; ROSS and KITTS 1973; FUHRMANN et 
al. 1989). The action of insulin is mainly antagonized by pancreatic glucagon which acts 
primarily to increase hepatic glucose output by promoting hepatic gluconeogenesis and 
glycogenolysis (MCDOWELL 1983). 
 
2.2.2    Hepatic Glucose Metabolism 
2.2.2.1 Hepatic Gluconeogenesis 
Since the absorption of glucose from the gut is low, there is no general need for the 
ruminant’s liver to remove excessive glucose from the portal vein. Therefore, ruminants have 
little or not detectable hepatic glucokinase activity; the rate-limiting enzyme in the glycolytic 
pathway (BALLARD et al. 1969). In turn, gluconeogenesis is very prominent in the bovine 
liver (YOUNG 1977). Approximately 90% of circulating glucose needed by the animal is 
provided through hepatic gluconeogenesis (YOUNG 1977; BELL 1995). The remaining 





from the postruminal glucose supply from the diets. It has been shown that the net hepatic 
glucose production (~3.1 kg/d) in early lactating dairy cows was more than adequate to meet 
the mammary glucose demands (~2.3 kg/d; REYNOLDS et al. 1988). According to an 
estimation by DANFÆR et al. (1995), 2 - 2.5 kg are needed daily for a cow at six month of 
pregnancy, which produced 25 kg of milk/day and gained 0.5 kg of body weight/day; ~90 - 
95% of that quantity were provided by endogenous hepatic glucose production through 
gluconeogenesis.  
 
Precursors for glucose synthesis include propionate, lactate, glycerol, and glucogenic 
amino acids (AA; HUNTINGTON et al. 2006). In fed animals, almost all of PDV-absorbed 
propionate is removed by the liver and used for glucose synthesis, generating ~50 - 60% of 
the total glucose entry. The remaining carbons are supplied by lactate and gluconeogenic AA 
(AMARAL et al. 1990; HUNTINGTON et al. 2006). The initial step of hepatic propionate 
metabolism is the activation of propionate to its coenzyme A derivative (propionyl-CoA) by 
the mitochondrial enzyme propionyl-CoA synthase (E.C. 6.2.1.17). Propionyl-CoA is 
carboxylated by the biotin-dependent enzyme, propionyl-CoA carboxylase (PCC; E.C. 
6.4.1.3), to form methylmalonyl-CoA which is metabolized to succinyl-CoA through the 
tricarboxylic acid cycle (TCA). Succinyl-CoA is converted to oxaloacetate (OAA) and then 
to phosphoenolpyruvate (PEP) by the action of phosphoenolpyruvate carboxykinase 
(PEPCK, EC 4.1.1.32). In rats, cattle, and several other species, the PEPCK enzyme has two 
isoforms which are compartmentalized to the mitochondria (PEPCK-M) and cytosol 
(PEPCK-C) with approximately equal activities (HOD et al. 1986; AGCA et al. 2002). 
However it has been shown that the mRNA abundance of hepatic PEPCK-C is greater than 
that of PEPCK-M in dairy cows; with a close relationship existing between total PEPCK 
enzyme activity and PEPCK-C mRNA level (AGCA et al. 2002). In addition, hepatic 
PEPCK-C activity and mRNA are regulated by nutritional and hormonal stimuli while 
PEPCK-M activity and mRNA levels appear to be constitutive (AGCA et al. 2002). 
 
Lactate and some of the glucogenic AA (e.g. alanine, cysteine,) are metabolized first to 
pyruvate and then directly to OAA through an ATP-dependent reaction catalyzed by pyruvate 
carboxylase (PC, EC 6.4.1.1). Then, OAA is shuttled to the cytosol as malate, from which 
NADH and OAA are regenerated, followed by PEP generation that is catalyzed by the 






Phosphoenolpyruvate is converted via several 3-carbon intermediates to fructose 1,6-
bisphosphate, which is hydrolyzed by fructose 1,6-bisphosphatase (FBPase, EC 3.1.3.11) to 
fructose 6-bisphosphate and inorganic phosphate (ENGELKING 2004). FBPase has been 
identified as the rate-limiting enzyme in hepatic glucose production from plasma glycerol 
which originated from adipose tissue as a result of lipolysis (RUKKWAMSUK et al. 1999; 
ENGELKING 2004). Glycerol enters the gluconeogenic pathway after conversion to 
dihydroxyacetone phosphate, the latter being a direct precursor of fructose 1,6-bisphosphate. 
 
After fructose 6-phosphate has been isomerised to glucose 6-phosphate, the final step of 
the gluconeogenic pathway is the dephosphorylation of glucose 6-phosphate by G6-Pase. G6-
Pase is found primarily in the liver and kidney, where it produces free glucose. Because this 
terminal step of glucose release is shared between both the gluconeogenic and the 
glycogenolytic pathways, G6-Pase activity is a key determinant in the output of glucose from 
the liver (VAN SCHAFTINGEN and GERIN 2002). 
 
2.2.2.2 Regulation of Hepatic Gluconeogenesis 
In general, the gluconeogenic rate in ruminants is mainly controlled by substrate availability 
from the diet (BBROCKMAN and LAARVELD 1986). In steers, increasing propionate 
supply by feeding sodium propionate increased the relative contribution of propionate to the 
carbon for gluconeogenesis from 43 % to 67 % (VEENHUIZEN et al. 1988). In a similar 
way, the contribution of AA to glucose production was positively correlated with dietary 
protein intake and hepatic AA entry rate (DANFÆR et al. 1995; WARY-CAHEN et al. 1997). 
When glucogenic precursor supply becomes excessive, increased hepatic glucoseneogenesis 
is balanced by anabolism or upregulation of glucose oxidation as it has been shown in steers 
(VEENHUIZEN et al. 1988) and sheep (JUDSON and LENG 1973a). 
 
Glucagon and insulin play important roles in the hormonal regulating of hepatic glucose 
metabolism in ruminants as in other species (MCDOWELL 1983). Glucagon acts primarily 
on the liver to increase hepatic glucose output by promoting gluconeogenesis and 
glycogenolysis in states of starvation and energy mobilization. It has been found that 
glucagon stimulates conversion of propionate to glucose in cultured hepatocytes from calves 
(DONKIN and ARMENTANO 1995), and from propionate and lactate in ovine hepatocytes 
(FAULKNER and POLLOCK 1990). The action of glucagon is mediated mainly through 





PILKIS et al. 1988). Elevation of intracellular cAMP leads to activation of cAMP-dependent 
protein kinases that catalyze the phosphorylation of a number of protein substrates. The end 
result of this cascade of events is a stimulation of gluconeogenesis and an inhibition of 
glycolysis (PILKIS et al. 1988). Insulin, on the other hand, opposes the action of glucagon to 
stimulate gluconeogenesis. One mechanism probably involves the ability of insulin to activate 
cAMP phosphodiesterase, which results in lower cAMP levels (PILKIS et al. 1988). In sheep, 
intravenous insulin infusion caused a marked decrease in the rate of hepatic glucose 
production and in net hepatic utilization of the gluconeogenic substrates alanin, glutamine, 
lactate and glycerol (BROCKMAN 1985; BROCKMAN 1990). Conversely, insulin has no 
effect on the rate of conversion of propionate to glucose (BROCKMAN 1990). Similarly, 
insulin has no effect on the conversion of propionate to glucose in monolayer cultures of 
hepatocytes isolated from ruminating calves (DONKIN and ARMENTANO 1995), but there 
was a decrease in glucose synthesis from lactate (DONKIN et al 1997). Using an 
hyperinsulinemic, euglycemic clamp, EISEMANN and HUNTINGTON (1994) showed that 
increased insulin supply in beef steers will reduce liver glucose production to the point where 
all glucose production could be derived from propionate. 
 
In non-ruminants, the most extensively studied gluconeogenic enzyme with regard to the 
hormonal regulation at the gene expression level is PEPCK (PILKIS et al. 1988). PEPCK 
gene expression was stimulated in the fasted state by glucagon, acting through cAMP, and 
was inhibited in the fed state by high levels of insulin (PILKIS et al. 1988; LEMAIGRE and 
ROUSSEAU 1994; CHRIST et al. 1988). In contrast, hepatic PEPCK mRNA levels of 
lactating dairy cows were decreased (SHE et al. 1999) or remained unchanged (WILLIAMS 
et al. 2006) when infused with glucagon. Although it is not well understood how insulin 
regulates the transcription rates of glucneogenesis enzymes mRNA expression in ruminants, 
SHE et al. (1999) suggested that PEPCK gene expression was down-regulated by an increase 
in the endogenous insulin secretion during infusions of glucagon. In monogastric animals, 
insulin has a depressive effect on hepatic glucose production by modulating the gene 
expression of PC (JITRAPAKDEE and WALLACE 1999), PEPCK (PILKIS et al. 1988), 
FBPase (EL-MAGHRABI et al. 1991) and G-6Pase (NORDLIE et al. 1999). 
 
2.3 Metabolic Disorders and Shortage in Glucose Supply 
The rapid increase in milk production after parturition greatly increases the demand for 





that for a milk yield of 30 kg/d, mammary requirements for glucose, AA and fatty acids at 4 
days postpartum are approximately 2.7, 2.0 and 4.5 times those of the gravid uterus during 
late pregnancy. Consequently, transition from pregnancy to lactation is a huge challenge to 
the metabolism of high-yielding lactating dairy cows.  
 
Limited feed intake during the early lactation; likely because of physiological stress and 
immune challenges, means that the supply of energy, espically the supply of propionate for 
glucose synthesis, is not sufficient to meet the energetic requirements of maintenance and the 
abundant milk secretion. Thus, the animal experiences a period of negative energy balance 
(NEB; BELL 1995; MARTENS 2007). Alteration of metabolism to sustain high levels of 
milk production during NEB results in mobilization of large amounts of body fat and the 
release of non-esterified fatty acids (NEFA) into the blood. The ability of the liver to utilize 
NEFA as fuel or export it as very low density lipoprotein (VLDL) is limited during periods of 
elevated plasma NEFA (e.g. postpartum NEB). When a limit is reached, excess fatty acids 
accumulate in the liver in the form of triacylglycerides (TAG), a condition referred to as fatty 
liver (GRUMMER 1993). As a consequence to the incomplete metabolism of mobilized 
NEFA, the acetyl-CoA that is not incorporated into the TCA is converted to ketone bodies 
(acetoacetate and β-hydroxybutyrate; BHBA). Appearance of these metabolites in blood, 
milk, and urine as a result of the excessive rate of ketogenesis is diagnostic of the metabolic 
disorder known as ketosis (GOFF and HORST 1997). Ketosis/fatty liver complex is 
associated with loss of appetite, central nervous system dysfunction, longer calving intervals, 
decrease in milk production and with increased veterinary costs (BOBE et al. 2004; GOFF 
2006). Therefore, improving the nutritional strategies to meet mammary gland glucose 
demands and also to minimizing such adverse consequences of glucose shortage is an area of 
current research in dairy nutrition. To alleviate glucose shortage in such periods, recent 
feeding strategies aim to increase glucose availability via postruminally digestible starch. 
 
2.4 Postruminal Starch Digestion and Glucose Absorption 
In ruminants, glucose availability in the small intestine is highly dependent on the type of the 
fed diet. For example, in ruminants fed on forage-based diets which contain essentially no 
starch carbohydrates, insignificant amounts of glucose would be available for absorption in 
the lumen of the small intestine, as documented in previous studies (JANSE et al. 1985a; 
HARMON and MCLEOD 2001). In contrast, many studies with lactating dairy cows and 





animals fed on a high starch diet (such as wheat, corn, sorghum, barley, and oats; JANSE et 
al. 1985b; REYNOLDS et al. 1994). Depending on a variety of conditions (e.g. grain type, 
processing); rumen escape starch can exceed 40% of the dietary starch intake in dairy cattle 
(ØRSKOV 1986; OWENS et al. 1986). The maximum amount of postruminal digestible 
starch has been estimated with ~1.5 - 2 kg/d in dairy cows (GÄBEL and ASCHENBACH 
2004). If this starch was digested and absorbed by the small intestine as glucose, it could 
contribute significantly to the total entry rate of glucose.  
 
There is evidence that the efficiency of conversion of dietary starch energy to tissue energy 
is greater in ruminants when glucose is absorbed directly as a result of postruminal starch 
digestion, rather than when dietary carbon is absorbed as SCFA, AA, and other glucose 
precursors (REYNOLDS et al. 1994; HARMON and MCLEOD 2001). Taken together, when 
starch that is resistant to ruminal degradation is fed, glucose absorption balances glucose 
utilization by PDV tissues, sparing endogenously synthesized glucose for tissue metabolism 
and, consequently, increasing total glucose availability to the mammary gland and to the rest 
of the body (NOCEK and TAMMINGA 1991; REYNOLDS et al. 1994).  
 
2.5    Metabolic Consequences of Increased Glucose Supply 
2.5.1 Lactation Performance 
The availability of glucose should be relevant for milk yield in view of the fact that lactose is 
the major osmoregulator for the transfer of water from the plasma to the milk (LINZELL and 
PEAKER 1971). In a number of studies conducted in lactating dairy cows fed on a grass 
silage-based diet, duodenal glucose infusion increased milk yield (HURTAUD et al. 2000; 
RIGOUT et al. 2002a,b; LEMOSQUET et al. 2004). However, with corn silage-based diet, 
postruminal glucose infusion had no effect on milk production (LEMOSQUET et al. 1997; 
HURTAUD et al. 1998). Since grass silage diet has a limited capacity to provide postruminal 
glucose for absorption compared with corn silage, this might indicate that the total availability 
of glucose in the doudenoum from postruminal starch and infused glucose might play role in 
the ability of infused glucose to increase milk yield (i.e. dose-dependent effect). In line with 
that, RIGOUT et al. (2002b) suggested that the differing responses of dairy cows to surplus 
glucose supply might be linked to such dose effects. Using duodenal glucose infusion in their 
study, moderate amounts of duodenal glucose were identified to increase the whole body 
appearance rate of glucose and mammary blood flow, leading to increased lactose synthesis 





which was explained by a decreased mammary conversion of glucose to lactose based on a 
decreased conversion of glucose 6-phosphate to glucose 1-phosphate in mammary tissue 
(RIGOUT et al. 2002b). In this regard, no study tested the dose effects of glucose on lactation 
performance using the intravenous administration route. The intravenous infusion route 
differs from the postruminal infusion route in that it avoids the release of gastrointestinal 
hormones that affect glucose metabolism and feed intake (HOLST  2007). Such hormonal 
effects could largely bias the true effect of glucose on lactation performance. The intravenous 
infusion route also avoids glucose utilization within the PDV (REYNOLDS et al. 1994) and, 
therefore, allows a more precise determination of dose effects of infused glucose with regard 
to the mammary function. 
 
Apart from milk yield, the effect of glucose on milk composition is also of interest. 
Excessive glucose has repeatedly been shown to modifiy milk composition. Most consistent 
results were decreases in milk fat yield (HURTAUD et al. 2000; RIGOUT et al. 2002a) and 
increases in milk protein yield (AMARAL et al. 1990; HURTAUD et al. 2000). Several 
theories have been proposed to explain the depression in milk fat which occurs during 
increases of glucose supply. The most widely held theory is the glucogenic-insulin theory 
which explains the depression in milk fat by a shortage in the supply of lipogenic precursors 
to the mammary gland (MCCLYMONT and VALLANCE 1962; BAUMAN and GRIINARI 
2003). According to this theory, increases in glucose availability would stimulate insulin 
secretion which, in turn, increases the rate of adipose tissues lipogenesis and inhibits lipolysis. 
These changes in the rates of lipid synthesis and lipolysis are proposed to preferentially direct 
nutrients to adipose tissue rather than mammary gland, thus causing a shortage of lipogenic 
precursors for mammary synthesis of milk fat (MCCLYMONT and VALLANCE 1962; 
BAUMAN and GRIINARI 2003). Another theory attributes milk fat depression during 
glucose infusion to a direct inhibition of mammary gland synthesis of milk fatty acids 
(LEMOSQUET et al. 1997; RIGOUT et al. 2002a,b). Numerous hypotheses have also been 
proposed to explain the increase in mammary gland protein synthesis by glucose infusion. 
Increasing glucogenic substrate (i.e., propionate) supply or glucose infusion may reduce the 
utilization of some glucogenic AA for gluconeogenesis and subsequently increase the supply 
of AA to the mammary gland (REYNOLDS et al. 1994). However, this kind of AA-sparing 
effect of glucose could not be prooved in a study by RULQUIN et al. 2004 where isoenergetic 
duodenal infusion of glucose did not increase arterial mammary glucogenic AA fluxes. 





mammary gland AA uptake, leading to increased mammary availability of AA for milk 
protein synthesis (MACKLE et al. 2000). 
 
2.5.2 Feed Intake   
Surplus glucose has had somewhat inconsistent effects on feed intake of dairy cows. Some 
studies have demonstrated that feed intake decrease with abomasal (FROBISH and DAVIS 
1976; CLARK et al. 1977) or intravenous (AMARAL et al. 1990) glucose infusions in dairy 
cows, whereas others have shown no change ( DHIMAN et al. 1993; KNOWLTON et al. 
1998). In non-ruminants, the hepatic branches of the vagus nerve carry signals from the liver 
to the brain which regulates many aspects of food intake and metabolism (LANGHANS et al. 
1985). Vagally mediated hepatic satiety signals are generated from extensive hepatic 
metabolism of glucose and other metabolic fuels (NIIJIMA 1983; LANGHANS et al. 1985). 
Since hepatic hexokinase activity is low in ruminants compared with non-ruminants 
(BALLARD et al. 1969), hepatic removal and oxidation of glucose appears to be 
insignificant. Therefore, part of the differences in the hypophagic effects of glucose supply 
observed between ruminants and non-ruminants could be related to the differences in hepatic 
oxidation of glucose according to the hepatic oxidation hypothesis (HOT; ALLEN 2000; 
ALLEN and BRADFORD 2007). In accordance with HOT, depression of feed intake by 
propionate infusions has been well documented in ruminants (ALLEN 2000). Increased 
hepatic oxidation of propionate during a meal would increase the energy state of hepatocytes, 
generating a satiety signal to terminate the meal (ALLEN et al. 2009). It had also been 
suggested that the hypophagic effects of propionate may be mediated by plasma insulin 
because high plasma insulin concentrations were correlated with a greater depression in DMI 
during high-grain feeding (BRADFORD and ALLEN 2007). However, the hypophagic effect 
of propionate infusions has been observed without an increase in the plasma insulin level in 
other studies (ALLEN et al. 2009). 
 
2.5.3    Glucose Metabolism 
2.5.3.1 Hepatic Glucose Production 
It has been suggested that hepatic glucose synthesis decreases in ruminants when the 
absorption of glucose from the gut increases (HUNTINGTON 1997). Intravenous, abomasal, 
or duodenal glucose infusion decreased the hepatic endogenous glucose production in dairy 
cows (BARTLEY and BLACK 1966; THOMPSON et al. 1975; CLARK et al. 1977; 





1996). These decreases were probably due to simultaneously observed increases in the blood 
insulin concentrations (THOMPSON et al. 1975; EISEMANN and HUNTINGTON 1994). 
However, some longer term infusions studies (>11d) showed no significant effect on 
endogenous glucose production (AMARAL et al. 1990; LARSEN and KRISTENSEN 2009). 
 
In monogastric animals, it has been shown that PEPCK activity is reduced with high-
carbohydrate diet and increased during fasting (LEMAIGRE and ROUSSEAU 1994). 
Exogenous glucose decreased PEPCK mRNA levels in the liver which resulted from an 
accelerated rate of mRNA degradation and from a decrease in the transcription rate 
(LEMAIGRE and ROUSSEAU 1994). G6-Pase gene expression may also be regulated by 
glucose via an insulin-independent pathway (NORDLIE et al. 1999). In ruminants, a limited 
number of studies showed that the pattern of liver gluconeogenesis enzymes changed during 
periods of increased glucose availability. Comparative studies showed that hormonal and 
nutritional regulations of PEPCK in ruminants are different from those in non-ruminants 
species (BALLARD et al. 1969; FILSELL et al. 1969). It has been shown that the activity and 
mRNA expression levels of hepatic PEPCK lacks appreciable sensitivity to dietary and 
hormonal changes in ruminants (FILSELL et al. 1969; GREENFIELD et al. 2000). However, 
one study by RUKKWAMSUK et al. (1999) observed a decrease in hepatic PEPCK activity 
in cows fed on a high-energy diet during the dry period. Intraduodenal infusion of glucose 
decreased the activity of liver G6-Pase in dairy cows (BARTLEY et al. 1966) and sheep 
(PEARCE and UNWORTH 1982). Also, the specific activity of FBPase was decreased in 
sheep fed on a concentrate diet (PEARCE and UNWORTH 1976). To present, no study 
addressed the dose effects of surplus glucose on gene expression and catalytic activity of 
hepatic gluconeogenesis enzymes in dairy cows. 
 
2.5.3.2 Peripheral Glucose Metabolism 
It has been shown in ruminants, that glucose became the first choice for oxidation by many 
tissues in the body when glucose supplies increased (KNOWLTON et al. 1998). Postruminal 
infusion of starch or glucose in lactating dairy cows increased the glucose irreversible loss 
rate (i.e. the rate at which glucose is utilized by, e.g., oxidation or milk lactose synthesis; 
AMARAL et al. 1990; KNOWLTON et al. 1998; RIGOUT et al. 2002b). Duodenal glucose 
infusions in an amount of 1.5 kg/day for 21 d doubled the rate of glucose oxidation as 
measured by the fraction of respiratory CO2 derived from plasma glucose (BARTLEY and 





plasma glucose increased from 4.1 to 6.8% with intravenous glucose infusion (737g/d for 11d; 
AMARAL et al. 1990) and from 5.4 to 7% by abomasal infusion of starch (1500g /d for 14d; 
KNOWLTON et al. 1998).  In line with that, increased utilization of glucose in gut tissues has 
been observed with interavenous glucose supply in sheep (1-2 mg/kg BW/min for 8 h; 
BALCELLS et al. 1995).  
 
2.5.4 Protein Metabolism 
When exogenous glucose supply to ruminants was increased by intravenous or postruminal 
glucose infusion, the urinary nitrogen excretion was reduced and the whole-body nitrogen 
retention increased (MATRAS and PRESTON 1989; OBITSU et al. 2000). In line with that, 
decreases in blood urea nitrogen (BUN) concentrations which indicate a decrease in AA 
catabolism have been described earlier during intravenous (AMARAL et al. 1990) or 
abomasal (OBITSU et al. 2000) glucose infusions. This protein-sparing effect of exogenous 
glucose may arise mainly through three mechanisms. Firstly, hepatic gluconeogenesis may be 
inhibited when sufficient exogenous glucose is supplied (BARTLEY and BLACK 1966; 
JUDSON and LENG 1973b) and hence sparing AA from hepatic utilization (REYNOLDS et 
al. 1994; VANHATALO et al. 2003). Secondly, an elevation of plasma insulin concentrations 
due to the glucose infusion can increase AA uptake by peripheral tissues (AHMED et al. 
1983). This stimulation of the peripheral uptake of AA may reduce the hepatic inflow of AA 
for urea synthesis (OBITSU et al. 2000). Finally, JAHOOR and WOLFE (1987) suggested 
that glucose may directly inhibit the hepatic capacity for urea synthesis. 
 
2.5.5    Lipid Metabolism 
2.5.5.1 Lipogenesis and Lipolysis 
It has been shown that acetate but not glucose is the major substrate for lipid synthesis in 
ruminant’s adipose tissue and liver. The mammary gland additionally uses appreciable 
amounts of BHBA for milk fat synthesis (INGLE et al. 1972; VERNON 1980). There is no 
doubt, however, that glucose is required to generate nicotinamide adenine dinucleotide 
phosphate (NADPH) needed for de novo fatty acids synthesis and is also the major precursor 
of the glycerol 3-phosphate needed for esterifying the fatty acids to TAG (VERNON 1980; 
NAFIKOV and BEITZ 2007). Surplus glucose thus increased the conversion of acetate into 
lipid in the ruminant’s liver (BALLARD et al. 1972). A similar effect occurred in adipose 
tissue but, in this tissue, glucose itself became a quantitatively important precursor of TAG 





1980; PEARCE and PIPEROVA 1984). Glucose administration to ruminants also reduced the 
plasma NEFA levels, mainly through an increase in insulin concentrations (VERNON 1980). 
Insulin is the key anabolic hormone of adipose tissue. It suppresses lipolysis and stimulates 
lipogenesis, resulting in a decrease of plasma NEFA concentrations (VERNON 1980).  
 
2.5.5.2 Mitochondrial Fatty Acid β-Oxidation 
Mitochondrial fatty acid β-oxidation involves three key steps: 1) uptake and activation of fatty 
acids to fatty acyl-CoA, 2) translocation of the activated fatty acyl-CoA into the mitochondria, 
3) β-oxidation of fatty acyl-CoA (BAUCHART et al. 1996). If β-oxidation becomes 
excessive, a fourth step becomes prominent, i.e. ketogenesis (DRACKLEY et al. 2001). The 
CPT system allows fatty acids to be translocated from the cystol to the mitochondrial matrix. 
The CPT system is composed of 3 enzymes: CPT-1, carnitine-acylcarnitine translocase 
(CACT), and CPT-2 (KERNER and HOPPEL 2000). CPT-1 is believed to be a key 
regulatory enzyme of cell NEFA metabolism by controlling the entry of NEFA into 
mitochondria for β-oxidation (KERNER and HOPPEL 2000). CPT-1 exists in three isoforms 
in mammalian tissues, CPT-1A, B and C. CPT-1A has been demonstrated in liver, kidney, 
brain, and pancreas; whereas, CPT-1B was highly expressed in muscle, heart and adipose 
tissue. CPT-1C appeared to be limited to the central neural tissues (RAMSAY et al. 2001).  
 
In monogastric animals, it has been shown that the concentration of malonyl-CoA, an 
intermediate precursor for de novo synthesis of fatty acids, is a critical factor regulating entry 
of fatty acid into the mitochondria for oxidation. In the carbohydrate-fed state, the insulin-to-
glucagon ratio increased, the rates of fatty acid synthesis were high, and hepatic malonyl-CoA 
formation was high. Under these conditions, the authors observed decreases in hepatic CPT-1 
activity and gene expression levels and an increase in CPT-1 sensitivity to inhibition by 
malonyl-CoA (KERNER and HOPPEL 2000). Vice versa, under conditions of increased fatty 
acid oxidation, e.g. starvation, hepatic CPT-1 becomes more active and less sensitive to 
inhibition by malonyl-CoA, resulting in an increase in hepatic fatty acids oxidation (KERNER 
and HOPPEL 2000). 
 
Inefficient hepatic β-oxidation of NEFA could be one of the predisposing factors for fatty 
liver in lactating dairy cows (DRACKLEY 1999). Therefore, it is of great importance to 
identify the factors that regulate the disposition of NEFA between oxidation and esterification 





activity through controlling the entry of NEFA into the mitochondria (JESSE et al. 1986a). 
Despite the fact that hepatic lipogenesis rate is low in ruminants, malonyl-CoA is also 
considered to be important in the partitioning of fatty acids between esterification and 
oxidation in ruminants, similar to what has been observed in non-ruminants species (JESSE et 
al. 1986a,b). Previous studies reported that insulin decreased hepatic CPT activity and the 
capacity for total hepatic NEFA oxidation in ruminants, presumably through increased 
malonyl-CoA concentration and increased sensitivity of CPT to malonyl-CoA inhibition 
(CHOW and JESSE 1992; ANDERSON et al. 2002). In dairy cows, the influence of 
nutritional status on CPT is evident from the observations that CPT activity increased or 
tended to increase during periods of NEB (DANN and DRACKLEY 2005; DOUGLAS et al. 
2006) and decreased when feeding a high-concentrate diet (AIELLO et al. 1984).  
 
In man, an increase in muscle glucose oxidation was linked to a rise of the intracellular 
concentration of malonyl-CoA, which is a potent inhibitor of CPT, and accordingly prevents 
the entry of fatty acids to mitochondrial oxidation (CAHOVÁ et al. 2007). Accumulation of 
intracellular lipids due to insufficient fatty acid oxidation, in turn, has been shown to suppress 
insulin signalling (CAHOVÁ et al. 2007), leading to insulin resistance (KREBS and RODEN 
2004). Therefore, impaired muscle LCFA oxidation and CPT activity might be involved in the 
mechanisms by which peripheral tissue insulin resistance developed by overconsumption of 
energy during the dry period in dairy cows (HOLTENIUS et al. 2003). Consequently, studies 
investigating the changes in skeletal muscle CPT activity relative to the energy balance are 
warranted in dairy cows.  
 
2.6 Main Objectives  
Given the considerable efforts to identify the metabolic responses to surplus glucose supply in 
dairy cows, there is still scarce information available on how intermediary metabolism adapts 
at different levels of glucose availability over a long time. The overall objectives of the 
present study were to investigate the effects of increasing rates of continuous glucose supply 
in mid-lactating dairy cows on lactation performance, body condition, and on some aspects of 
liver and skeletal muscle glucose and lipid intermediary metabolism. The present study was 
carried out to address precisely these questions: 






 To what upper limit can cows adapt to surplus glucose without dysregulation of 
glucose homeostasis?. Further, if dysregulation of glucose homeostasis occured, might 
it be linked to compromised insulin sensitivity of peripheral organs?  
 What is the dose effect of surplus glucose on gene expression and catalytic activity of 
key hepatic gluconeogenesis enzymes in dairy cows?  
 What is the dose effect of surplus glucose on body protein metabolism?  
 What is the possible fate of infused glucose?  
 What is the dose effect of glucose supply on lipid metabolism?  
 Do the catalytic activities of CPT in liver and skeletal muscle respond in a co-ordinate 
manner to positive energy balance or not?  
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The present study aimed at investigating whether increasing levels of glucose supply have a 
depressive effect on the mRNA abundance and activity of key gluconeogenesis enzymes in 
dairy cows. Twelve Holstein-Friesian dairy cows in mid-lactation were intravenously infused 
with either saline (SI; n = 6) or a 40% glucose solution (GI; n = 6). For GI cows, the infusion 
dose increased by 1.25%/d relative to the initial NEL requirement until a maximum dose 
equating to surplus 30% NEL was reached on d 24. Cows receiving SI received an equivalent 
volume of 0.9% saline solution. Blood samples were taken every 2 d and liver biopsies were 
collected every 8 d. A treatment × quadratic dose interaction was observed for both the 
concentration of plasma glucose and serum insulin. The interactions were due to positive 
quadratic responses of the concentrations of glucose and insulin for GI cows whereas; the 
concentrations of glucose and insulin did not change over time for SI cows. The concentration 
of β-hydroxybutyric acid (BHBA) and serum urea nitrogen (BUN) responded in a treatment × 
quadratic dose manner such that greater decreases in BHBA and BUN concentrations were 
observed for cows receiving GI than SI as the dose level increased. Serum NEFA 
concentration tended to follow a similar pattern as serum BHBA and BUN, however, the 
interaction was not significant. The mRNA abundance of gluconeogenesis enzymes followed 
a linear treatment x dose interaction for only pyruvate carboxylase (PC), which was paralleled 
by a trend for a linear treatment x dose interaction for PC enzyme activity. The lowest PC 
expression and activity were observed at the highest glucose dose. The activity, but not 
mRNA abundance, of fructose 1,6-bisphosphatase (FBPase) showed treatment x quadratic 
dose interactions with decreasing activity at increasing glucose dose. Activities and 
expression levels of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase were not 
affected by treatment. In conclusion, hepatic gluconeogenesis enzymes are only moderately 
affected by slowly increasing glucose supply, including a translational or posttranslational 
downregulation of FBPase activity and a decrease in the mRNA abundance of PC with 
possible consequences for PC enzyme activity. 







The majority of ingested carbohydrates are converted to short chain fatty acids in the 
forestomach of ruminants (Young, 1977; Seal and Reynolds, 1993). Under many dietary 
settings, this implies low availability of glucose for absorption (Baird et al., 1980; Reynolds et 
al., 1988); thereby, generating a need for hepatic gluconeogenesis (Young, 1977). Efficient 
gluconeogenesis is especially important in dairy cows because it is the major pathway for 
maintaining adequate glucose supply for the mammary gland (Reynolds et al, 1988; 
Huntington et al., 2006). When cows approach peak lactation, insufficient gluconeogenesis 
might contribute to the occurrence of metabolic disorders like ketosis and fatty liver (Mills et 
al., 1986; Rukkwamsuk et al., 1999; Murondoti et al., 2004). Consequently, knowledge on the 
regulation of hepatic gluconeogenesis has implications for both the performance and the 
health status of dairy cows. 
While surplus supply of glucose has often been shown to downregulate hepatic glucose 
production (Bartley and Black, 1966; Thompson et al., 1975; Lomax et al., 1977; Rigout et 
al., 2002), it is a crucial question whether this also involves a down-regulation of the involved 
enzymes. A down-regulation of gluconeogenic enzymes could have consequences extending 
beyond the period of surplus glucose or glucogenic substrate supply. For example, a down-
regulation of gluconeogenic enzymes in cows overfed prepartum could exacerbate metabolic 
disturbances during the post-partum phase of the transition period (Rukkwamsuk et al., 1999; 
Murondoti et al., 2004). Therefore, the objective of this study was to investigate the dose effect 
of intravenous glucose infusion on the mRNA abundance and activity of key enzymes of 
hepatic gluconeogenesis. The hypothesis was that mRNA abundance and activity of hepatic 
gluconeogenic enzymes would decrease with increasing dose of glucose and that, at least, the 






MATERIALS AND METHODS 
Animals and Experimental Design 
Experimental procedures were pre-approved by the local authorities, Regierungspräsidium 
Leipzig (reference 24-9168.11, TVV 49/06). The use of animals, the general experimental 
design and the production traits during the experiment have been described in detail in a 
previous report (Al-Trad et al., 2009). In brief, experiments were carried out on 12 Holstein-
Friesian cows from the dairy herd of the University of Leipzig. Cows were confirmed to be in 
the 2nd to 4th month of gestation (193 ± 14 DIM) at the start of the experiment and had an 
average BW and energy-corrected milk yield of 632 ± 33 kg and 30.5 ± 2.3 kg/d, respectively. 
Cows were housed in individual tie stalls with straw bedding. Twice daily (0600 and 1500 h), 
cows received a diet based on grass haylage and supplements containing a commercial energy 
concentrate for lactating dairy cows (Multilac, Leikra GmbH, Leipzig, Germany) and soybean 
meal. The ingredient and chemical composition of the diet has previously been reported (Al-
Trad et al., 2009). The diet was low in starch (11.3% DM) and sugar content (4.4% DM) in 
order to minimize the direct entry of glucose from the digestive tract. Water was available for 
ad libitum intake. Cows were milked at 0630 and 1600 h. 
 
Cows were assigned to either a glucose infusion (GI; n = 6) or saline infusion (SI; n = 6) 
treatment balanced for actual lactation performance and DIM. Infusions were made via a 14-
ga, 20-cm jugular catheter (Cavafix Certo Splittocan 338, Melsungen, Germany) which was 
replaced every 8 d. Glucose infusion treatment consisted of continuous jugular infusions of 
40% glucose solution (Serumwerk Bernburg, Bernburg, Germany) over a period of 28 d. The 
infusion dose was calculated for each animal individually as a percentage of their daily NEL 
requirement at the start of the study (see Calculations and Statistical Analysis). Dose level 
was 0% of the NEL requirement on d 0 and increased linearly by 1.25% each day until a 
maximum dose of surplus 30% of the NEL requirement was reached at d 24. This was 
equivalent to 2.65 ± 0.19 kg glucose per cow per day. After maintaining the infusion dose at 
30% of the NEL requirement between d 24 and 28, responses to glucose withdrawal were 
assessed by withholding infusions between d 29 and 32. Infusion canisters were loaded at 
1500 h each day, starting in the afternoon of d 0. This assured that cows had been on the 
assigned dose level for at least 19 h prior to the collection of biopsies (see below). The 
infusion protocol and the individual calculation of infusion volumes were identical for the SI 





equivalent dose of 0.9% saline (Serumwerk Bernburg, Bernburg, Germany) as a control 
treatment. 
 
Sampling and Measurements 
Liver biopsies were obtained between 1000 h and 1200 h on d 0, 8, 16, 24, and 32 with a 2.5-
mm wide, 250-mm long biopsy needle (Model Berlin, Walter Veterinär-Instrumente, 
Rietzneuendorf, Germany) under ultrasonography control (Pie Medical Scanner 100 LC, Pie 
Medical, Maastricht, The Netherlands) as described by Gröhn and Lindberg (1982). 
Following collection, liver samples were washed immediately in ice-cold 0.9% saline 
solution. Samples for enzyme activity determinations (~ 200 mg) were snap frozen in liquid 
nitrogen and stored at -80 °C. Samples (~300 mg) for real-time reverse transcription-
polymerase chain reaction (rt-PCR) were transferred into tubes with 3 mL RNAlater (Qiagen, 
Germantown, MD), placed in a refrigerator for 24 h, and stored at -20 °C thereafter. 
 
Blood samples were taken from a coccygeal vein every 2 d at 1000 h and processed as 
described previously. Monovette tubes with heparin (16 IU lithium heparin/ml blood; 
Sarstedt, Nümbrecht, Germany) were used to obtain plasma for glucose analysis. Kaolin-
coated Monovette tubes (Sarstedt) were used for serum preparation to determine insulin, 
serum urea nitrogen (BUN), non-esterified fatty acids (NEFA), and β-hydroxybutyric acid 
(BHBA) concentrations. All plasma and serum samples were stored at –20 °C. 
 
Blood Analyses 
An automatic analyzer (Hitachi 912, Boehringer Mannheim, Mannheim, Germany) was used 
to analyze the concentrations of plasma glucose (glucose/HK kit; Roche Diagnostics GmbH., 
Mannheim, Germany; Peterson and Young, 1965), serum BUN (urea/BUN kit; Roche; Talke 
and Schubert, 1965), serum NEFA (NEFA kit; Randox Laboratories Ltd., Crumlin, UK; 
Matsubara et al., 1983) and serum BHBA (Ranbut/kit; Randox; McMurray et al., 1984). A 
radiometric immunoassay was used for analysis of serum insulin (INS-IRMA Kit; BioSource 
Europe SA, Nivelles, Belgium) which has a high specificity for insulin and no significant 
cross-reactivity to proinsulin (Temple et al., 1990). The kit originally comes with a human 
calibration standard. However, we routinely prepare calibration standards by diluting bovine 
insulin in the human insulin-free serum provided with the test to account for the partial 






Gluconeogenic Enzymes Activity 
The activities of the following key hepatic gluconeogenic enzymes was measured: pyruvate 
carboxylase (PC, EC 6.4.1.1), phosphoenolpyruvate carboxykinase (PEPCK, EC 4.1.1.32), 
fructose 1,6-bisphosphatase (FBPase, EC 3.1.3.11), and glucose 6-phospatase (G6-Pase, EC 
3.1.3.9). For PC and PEPCK assays, liver tissues were homogenized with an Ultra-Turrax T25 
homogenizer (IKA, Staufen, Germany). Thereafter, mitochondria were disrupted by 
sonication (Bandelin Sonoplus HD 2070; Bandelin Electronic, Germany) according to the 
protocol of Agca et al. (2002). Pyruvate carboxylase activity was assayed 
spectrophotometrically at room temperature using the previously published method of 
Crabtree et al. (1972). This procedure measures the reduction of 5,5'-dithiobis-2-nitrobenzoic 
acid by CoA. The latter is released when citrate synthase couples acetyl-CoA to oxaloacetate 
emerging from the PC reaction. Activity of PEPCK was measured at 37 °C based on the 
14CO2 incorporation assay of Ballard and Hanson (1967) with the modifications described by 
Agca et al. (2002). To avoid the release of 14CO2 into the environment, the 14CO2 not 
incorporated into oxaloacetate was trapped in barium hydroxide (0.2 M) at the end of the 
procedure. 
 
For FBPase and G6-Pase assays, tissues were homogenized (1:10, w/v) in ice-cold 
homogenization buffer containing 20 mM HEPES, 100 mM sucrose and 0.25 mM EDTA (pH 
7.4). The homogenate was centrifuged for 5 min at 1,000 × g to remove cell debris. The 
supernatant was recentrifuged at 10,000 × g for 10 min. The resulting supernatant was used to 
determine FBPase and G6-Pase activities by the methods of Marcus et al. (1973) and 
Swanson (1950), respectively. The latter methods spectrophotometrically measure the release 
of inorganic phosphate from either fructose 1,6-bisphosphate or glucose 6-phosphate. 
 
RNA Isolation and Quantitative rt-PCR 
Ribonucleic acid was extracted from liver tissues stored in RNAlater using Trizol reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The resulting RNA 
pellets were dissolved in RNase-free water and the quantity and quality of the isolated RNA 
were determined by absorbance at 260 and 280 nm. Total RNA (1 µg) was reverse transcribed 
using oligo-(dT)15 primer in a 20-µl reaction according to the manufacturer's instructions 
(AMV-RT kit, Roche Diagnostics, Mannheim, Germany). Reverse transcription reactions 
were carried out at 25 °C for 10 min followed by 42 °C for 60 min and 95 °C for 5 min. The 






Quantitative rt-PCR was carried out on a Rotor-Gene 6000 (Corbett Research, Australia), 
using β2-microglobulin (B2M) as non-regulated reference gene. Primers and dual-labelled 
fluorescent probes (Table 1) for quantitative rt-PCR were designed using the web-based 
quantitative rt-PCR probe design software provided by MWG Biotech AG (Ebersberg, 
Germany, http://www.eurofinsdna.com/de/home.html) and synthesized by the same company. 
To ensure the specificity of the primers and probes, a gel was run, in which a single band of 
expected size was obtained. Primer and probe concentrations were optimized to the 
concentration that provided the lowest fluorescence threshold cycle (CT) values and the 
highest increase of fluorescence compared to the background. For each sample, the target 
gene and the control gene were run under duplex reaction conditions in duplicate. The 
following reagents were used for amplification in 20 μl final volume: 1 μl of sample cDNA, 
2 μl Mg-free 10X buffer, 0.75 U Dynazyme II DNA polymerase (Finnzymes, Espoo, 
Finland), 5.5 mM MgCl2, 0.3 mM dNTP, 900 nM of each primer and 150 nM of each probe 
for the genes of interests, and 200 nM of each primer and 50 nM of the probe for the B2M. 
Amplification conditions for quantification were: 95 °C for 2 min and 45 cycles of 95 °C for 
30 s, 55 °C for 30 s and 72 °C for 30 s. After the amplification efficiency of each target and 
reference gene was validated, the relative gene expression levels were determined by the 2-
ΔΔCT method as described by Livak and Schmittgen (2001). Level of gene expression was 
expressed as the normalized ratio of gene expression relative to B2M mRNA level using one 
sample from the SI group as an interplate calibrator. The suitability of B2M as a reference 
gene was checked by demonstrating that B2M CT values at the beginning of the experiment 
(i.e. d 0) were not different from those obtained with later samples (d 8, 16, 24, 32) in both 






  1B2M, β2 microglobulin; PEPCK-C, cytosolic phosphoenolpyruvate carboxykinase; PEPCK-M, mitochondrial phosphoenolpyruvate carboxykinase;  
 
Table 1. Sequences of primers and probes used for quantitative real time RT-PCR 











































PC, pyruvate carboxylase; FBPase, fructose 1,6-bisphosphatase; G6-Pase, glucose 6-phosphatase, catalytic subunit. 
2FAM, 6-carboxy-fluorescein; TAMRA, 6-carboxy-tetramethylrhodamine; JOE, 2,7-dimethoxy-4,5-dichloro-6-carboxyfluorescein; ROX, 6-carboxy-X-rhodamine;  






Calculations and Statistical Analysis  
Net energy required for maintenance and lactation (MJ/d) was calculated as 4.184 × ([BW0.75 
× 0.08] + milk yield (kg) × [(0.0929 × fat %) + (0.0563 × protein %) + (0.0395 × lactose %)]) 
according to the NRC (2001). Based on the energy requirement of the individual cow, 
infusion dose (kg glucose/d) was calculated as follows; designated dose level × NEL/(15.6 
MJ/kg).  
 
All data were analyzed using the PROC MIXED procedure of SAS (version 9.1.3; SAS 
Institute Inc., Cary, NC; ref. SAS, 2002) accounting for repeated measures. The model to test 
for global effects of treatment, dose and the dose x treatment interaction included the fixed 
effects of treatment (GI vs. SI), dose (representing dose levels of 0, 10, 20, and 30% NEL 
requirement) and their interaction. The NEL calculated prior to the start of the experiment was 
used as a covariate. In addition, because cows were gradually exposed to increasing dose 
levels; dose was included in the model as a repeated measure. The covariate error structure 
which yielded the lowest Akaike’s and Bayesian information criterion values for each 
dependent variable was used. Because the first part of the statistical model could not account 
for the steady increase in dose over time, we continued to assess the slopes of the responses of 
the infusion dose and their interaction with treatment (i.e. linear vs. quadratic effects) using 
the same model except that dose was considered to be a continuous variable. The biological 
significance of the statistical tests was finally assessed based on the treatment effects derived 
from the first model, and the linear and quadratic responses of dose and treatment × dose 
derived from the second model (Table 2). Priority was given to treatment × dose interactions 
because dose effects can be partially confounded by time and infusion volume effects given 
the long duration of the experiment and the constant increase in infusion volume.. 
Comparisons of post-infusion samples (d 32) to pre-infusion samples (d 0) were performed 
using a Student’s paired t-test. Differences were considered significant when P < 0.05 and 




Production data from this study have been reported previously (Al-Trad et al., 2009). Briefly, 
dry matter intake was not different between the GI and SI groups over the period from d 0 to 
d 24 (period mean ± pooled SEM for GI vs. SI cows: 17.5 vs. 17.7 ± 0.9 kg/d). 





0 and d 24 (from -14.6 to 35.4 MJ/d); while it was unchanged in the SI group during the same 
period (from -10.4 to -1.8 MJ/d; pooled SEM: 6.3 MJ/d). The improved energy balance was 
coupled to a net BW gain of 32 kg in GI cows (from 651 to 670 kg) relative to the SI cows 
(from 614 to 601 kg; pooled SEM: 28 kg), while the energy-corrected milk yield was not 
affected by the treatment (period mean between d 0 and d 24 ± pooled SEM: 27.8 and 29.7 ± 
1.9 kg/d for GI and SI cows, respectively) (Al-Trad et al., 2009). 
 
Plasma and Serum Metabolites and Hormones 
Plasma glucose and serum insulin concentrations showed predominantly quadratic dose 
effects and treatment × quadratic dose interactions (P < 0.05; Figure 1A and 1B, 
respectively). Additionally, there was a treatment effect on serum insulin concentration (P = 
0.005) and a trend for a treatment effect on plasma glucose concentrations (P = 0.06). These 
effects were due to increases in plasma glucose and serum insulin concentrations in the GI 
group occurring mainly when infusion doses exceeded 20% NEL requirement; whereas, cows 
receiving the SI treatment had no response to increasing dose level (Figure 1). 
 
Treatment did not affect the concentrations of BUN, BHBA, and NEFA; however, BUN, 
BHBA and NEFA decreased in a quadratic manner in response to increasing dose level (P = 
0.001; Figure 2A-C). Additionally, treatment × quadratic dose interactions were detected for 
BUN and BHBA (P = 0.001), and tended to be present for NEFA (P = 0.07), indicating that 
the concentrations of these metabolites decreased specifically with increasing dose of glucose. 
In contrast to glucose and insulin concentrations, however, the major part of the decrease in 
BUN, BHBA, and NEFA concentrations occurred at low infusion levels < 20% NEL 
requirement. 
 
Post-infusion values (d 32) were lower in the GI group for NEFA compared to pre-
treatment values (d 0). However, glucose, insulin, BHBA, and BUN values were not different 
between d 0 and d 32 in both groups, indicating a quick reversal of the GI effect on these 







Figure 1.  Plasma glucose (A) and 
serum insulin concentrations (B) of 
cows treated with glucose (■) or 
saline (●). 
 Open symbols depict pre- and post-
infusion values that were not 
included in statistical trend 
modeling. Data are expressed as 
least square means; pooled SEM: 
0.31 mmol/L (A), 120 pmol/L (B). 
Probability levels for statistical 
contrasts were as follows; treatment: 
0.06 (A), 0.005 (B); dose linear: 
0.03 (A), 0.10 (B); dose quadratic: 
0.02 (A), 0.001 (B); treatment × 
dose linear: 0.61 (A), 0.44 (B); 
treatment × dose quadratic: 0.001 
(A), 0.006 (B). Post-infusion values 
(d 32) were not different from pre-








Figure 2.  Serum urea nitrogen (BUN; 
panel A), beta-hydroxybutyric acid 
(BHBA; panel B) and nonesterified 
fatty acid (NEFA; panel C) 
concentrations for blood samples taken 
every 2 d for cows treated with glucose 
(■) or saline (●).  
  Open symbols depict pre- and post-
infusion values that were not included 
in statistical trend modeling. Data are 
expressed as least square means; pooled 
SEM, 1.6 mg/dL (A), 0.15 mmol/L (B), 
29 µmol/L (C). Probability levels for 
statistical contrasts were as follows; 
treatment: 0.22 (A), 0.98 (B), 0.56 (C); 
dose linear: 0.001 (A), 0.06 (B), 0.001 
(C); dose quadratic: 0.001 (A), 0.001 
(B), 0.001 (C); treatment × dose linear: 
0.12 (A), 0.76 (B), 0.19 (C); treatment × 
dose quadratic: 0.001 (A), 0.001 (B), 
0.07 (C). Post-infusion values (d 32) 
were different to pre-infusion values (d 





Hepatic mRNA Abundance and Activity of Gluconeogenic Enzymes 
Hepatic gluconeogenic enzyme activity and relative mRNA abundance levels are listed in 
Table 2. Treatment did not affect the mRNA levels or enzyme activity measured in this study. 
However, the relative mRNA abundance of PC showed a linear treatment × dose interaction 
(P = 0.048) and a tendency for a quadratic dose effect (P = 0.06), indicating decreased 





mRNA coincided with a numerical decrease in PC activity only at the highest dose of glucose 
(linear treatment × dose interaction, P = 0.13). The relative mRNA abundance levels of the 
mitochondrial isoform of PEPCK (PEPCK-M) decreased already at low infusion level (10 % 
NEL requirement) in a quadratic manner (P = 0.01), and the expression of the cytosolic 
isoform of PEPCK (PEPCK-C) tended to decrease linearly (P = 0.07) with increasing dose. 
Corresponding to the decreases in the mRNA abundance for PEPCK, the enzyme assay 
showed a linear decrease in PEPCK activity with increasing glucose dose (P = 0.03). 
However, the decreases in PEPCK mRNA abundance and enzyme activity occurred in both 
the SI and GI groups with no significant treatment × dose interactions, indicating time-
dependent or infusion volume-dependent changes with no relationship to glucose treatment. A 
linear decrease in both groups with no treatment × dose interaction was also observed for 
FBPase mRNA abundance. However, FBPase activity remained stable in the SI group despite 
the decreasing mRNA levels but was decreased in the GI group at the highest dose level of 
30% NEL requirement (treatment × quadratic dose, P = 0.02). Treatment did not affect the 
mRNA abundance of G6-Pase; although a quadratic decrease with increasing dose (P = 0.02) 
was observed for both treatments. Similarly to PEPCK-M, the steepest decrease in the mRNA 
abundance of G6-Pase occurred already at low infusion dosages of 10% NEL requirement. 
However, the activity of G6-Pase was not affected by treatment, dose or their interactions. As 
such, the changes of mRNA abundance and enzyme activity were uncoordinated for FBPase 
and G6-Pase, indicating that mRNA abundance had no measurable influence on the activity of 
these enzymes. 
 
The significantly or numerically decreased activities of FBPase and PC and the decreased 
transcription of PC in the GI group were restored to pre-infusion values by d 32, i.e. at 4 d 
after suspending the infusion (Table 2). Similarly, PEPCK mRNA abundance and activity was 
restored to pre-infusion values except for a slight remaining reduction in PEPCK activity in 
the SI group (P = 0.02). However, the activity of G6-Pase was decreased in the GI but not the 
SI group after stopping infusion (P = 0.02), although G6-Pase mRNA abundance increased to 











Hepatic gluconeogenesis is a key component of total glucose entry in cattle (Young, 1977; 
Huntington et al., 2006). Approximately 60 - 85% of the glucose entry is utilized by the 
mammary gland in lactating dairy cows (Annison et al., 1974; Bickerstaffe et al., 1974). 
Consequently the kinetics and regulation of gluconeogenesis are an area of great interest with 
regard to milk production. The fact that a number of previous studies failed to detect a 
positive influence of surplus glucose supply on milk production (Amaral et al., 1990; Hurtaud 
et al., 1998; Al-Trad et al., 2009) supports the concept that gluconeogenesis is mostly 
functioning at a very appropriate level with regard to lactation requirements (Al-Trad et al., 
2009). 
 
As with any biochemical pathway, the regulation of gluconeogenesis may occur at one or 
more of the following levels; (1) regulation of substrate supply, (2) regulation of activity of 
catalytic enzymes, and (3) regulation of end-product utilization. Of these, glucogenic 
substrate supply is considered the control point best amenable to feeding management 
(Veenhuizen et al., 1988; Overton et al., 1999). Increasing the entry rate of propionate and 
glucogenic amino acids from the portal-drained viscera has become a successful strategy to 
support cattle in periods of glucose shortage; especially in the critical period postpartum. Such 
strategies include measures to increase DMI, to modify fermentation patterns, or to directly 
add glucogenic precursors to the diet (Overton and Waldron, 2004). On the other hand, 
upregulation of glucose oxidation or anabolism are primary adaptations of ruminants 
themselves in times of excessive supply of glucogenic precursors (Judson and Leng, 1973a; 
Veenhuizen et al., 1988) or glucose (Amaral et al., 1990; Rigout et al., 2002). However, data 
is limiting on how the regulation of catalytic activity is utilized to meet imbalances between 
glucogenic precursor/glucose availability and glucose demand. 
 
The present study was designed to evaluate the effect of increasing glucose supply on four 
key hepatic gluconeogenesis enzymes in mid-lactating dairy cows. The intention was to 
explore the whole range of nutritionally relevant surplus glucose. When assuming postruminal 
starch digestion as the major way to provide glucose directly to dairy cows and proceeding 
from maximum rates of postruminal starch digestion in the order of ~5 kg/d (McCarthy et al., 
1989; Taylor and Allen, 2005), a functional maximum uptake capacity (fMUC) of the small 
intestine can be calculated in the range of ~2.8 kg glucose/d according to the formula of Cant 





of 30% NEL requirement (i.e., 2.65 kg glucose/d). It became clear that this infusion dose may 
not only be representative for the intestinal limit of glucose absorption. It is also a dose at 
which cows show dysregulation of glucose homeostasis as evidenced by elevated 
concentrations of blood glucose and insulin. Obviously, the limit of intestinal absorption of 
glucose and the ability to use the absorbed glucose appear highly coordinated in dairy cows. 
 
The present study additionally modeled the whole range of gluconeogenic requirement in 
order to meet the glucose demand. Diets were formulated to be low in starch and sugar to 
provide basal conditions with minimized direct entry of glucose from the digestive tract. 
Consequently, hepatic gluconeogenesis had to meet the complete demand for glucose entry at 
the beginning of the experiment. By contrast, the infusion dose of 2.65 kg glucose/d at the end 
of the GI period completely accounted for the glucose demand, which would be 2.27 kg/d at 
27.8 kg ECM/d according to the formula by Danfær (1994). The latter means that 
gluconeogenesis was, in theory, completely dispensable at an infusion dose of 30% NEL 
requirement. 
 
The main finding was that the effect of GI on gluconeogenic enzyme activity was very 
moderate. Enzymatic activity decreased (or tended to decrease) for only FBPase and PC, and 
only at extremely high levels of surplus glucose supply (i.e. infusion of 30% NEL 
requirement). Moreover, both decreases were rapidly reversible within 4 days after the end of 
infusion. We further elucidated that the glucose-induced decreases in enzyme activity were 
not linearly related to decreased mRNA abundance because mRNA abundance and enzyme 
activity changed in a coordinated manner only for PEPCK with a tendency for PC, indicating 
that the activities of FBPase and G6-Pase are predominantly regulated by translational and 
posttranslational events. 
 
Three of the investigated enzymes, PEPCK, FBPase and G6-Pase, belong to the common 
gluconeogenic pathway while PC serves to shuttle lactate and glucogenic amino acids into 
this pathway (Pilkis and Granner, 1992; Jitrapakdee and Wallace, 1999). Unlike in 
monogastric species, lactate and glucogenic amino acids are not the dominating glucogenic 
precursors in ruminants where propionate is quantitatively most important (Amaral et al., 
1990; Huntington et al., 2006). Propionate enters the common gluconeogenic pathway at the 
level of PEPCK after initial conversion by propionyl-CoA carboxylase to oxaloacetate 





limiting enzyme involved in glucose production from propionate in dairy cows (Greenfield et 
al., 2000). Although the rate of propionate utilization for hepatic gluconeogenesis was not 
measured in the current study, the non-significant treatment × dose interaction for the 
expression and activity of PEPCK provides indirect support that infused glucose did not 
specifically compromise gluconeogenesis from propionate at the PEPCK level. Previous 
glucose metabolism studies in ruminants confirm this suggestion by showing that hepatic 
propionate extraction efficiency and capacity for glucose synthesis from propionate are very 
resistant to changes in glucose supply (Judson and Leng, 1973b; Baird et al., 1980) and 
insulin levels (Brockman, 1990; Eisemann and Huntington, 1994; Huntington et al., 2006). 
Therefore, our enzyme measurements in context with previous investigations on glucose 
metabolism support the view that the liver of ruminants has a high metabolic priority to utilize 
propionate for gluconeogenesis (Brockman, 1990; Huntington et al., 2006). This conclusion is 
not surprising because over 90% of portal propionate is cleared by the liver and most of this 
amount is used for hepatic glucose synthesis (Armentano, 1992). Efficient propionate 
clearance and metabolism might not only be important for the glucose balance in lactating 
dairy cows but may also prevent adverse consequences of propionate accumulation in the 
blood (e.g. decreased feed intake; Allen et al., 2005). 
 
In contrast to PEPCK, mRNA abundance of PC tended to be specifically suppressed by GI. 
This confirmed earlier findings that PC mRNA abundance is most consistently changed with 
varying levels of glucose or energy supply in ruminants (Bradford and Allen, 2005; Velez and 
Donkin, 2005; Loor et al., 2006). Coincidence of a decrease in the mRNA abundance of PC 
(by 51% at 30% NEL requirement) with a numerical decrease in PC activity at the highest 
dose of glucose (by 49% at 30% NEL requirement) might suggest some contribution of 
decreased PC transcription to the decreased enzyme activity. It may be speculated that the 
observed decrease in PC enzyme activity, although not statistically significant, might have 
contributed to a decreased deamination of amino acids because PC is required for hepatic 
glucose synthesis from glucogenic amino acids (Greenfield et al., 2000; Velez and Donkin 
2005). A decreased deamination of amino acids, in turn, was suggested by the decreased 
serum BUN concentration in the GI group and has the unique metabolic advantage of sparing 
amino acids for protein synthesis pathways (e.g. muscle or milk protein synthesis). 
 
An enzyme activity significantly affected by GI was FBPase but only at the highest dose of 





glucose/d). The linear treatment × dose interaction was only evident at the enzyme activity 
level and not at the mRNA level, indicating posttranscriptional regulation of enzyme activity. 
FBPase is the enzyme that releases fructose 6-phosphate from the gluconeogenic pathway 
(Pilkis and Granner, 1992) which, after conversion to glucose 6-phosphate, can release 
glucose by the action of G6-Pase (see below). FBPase thus controls the overall output of 
gluconeogenesis regardless of the precursors utilized. Consequently, the decrease in FBPase 
activity might be seen as an effective measure to counteract hyperglycemia occurring at very 
high infusion levels. The decrease in FBPase activity could be directly related to the 
hyperglycemia because excess glucose, together with insulin, stimulates the intracellular 
accumulation of fructose 2,6-bisphosphate, which is a potent competitive inhibitor of FBPase 
(Pilkis et al., 1988; Pilkis and Granner, 1992). Additionally, a rapid proteasomal degradation 
of FBPase has been demonstrated in yeast upon exposure to glucose (Gancedo, 1971; Brown 
and Chiang, 2009). The rapid translocation of FBPase to the nucleus observed in cultured rat 
hepatocytes after exposure to glucose or insulin (Yáñez et al., 2004) could indicate that 
similar proteasomal degradation of FBPase is possible in the mammalian liver during 
hyperglycemia. 
 
Apart from investigating the dose effects of glucose, the second intention of the present 
study was to test the response in gluconeogenic capacity after withdrawing an extremely high 
glucose load. It became evident that PC mRNA abundance and FBPase activity were fully 
restored within only four days after withdrawing GI. This supports the view that 
gluconeogenic enzymes in cattle liver adapt rapidly to changes in glucose supply. On the 
other hand, it indicates that the dysregulation or maladaptation of gluconeogenic enzymes 
described in postparturient dairy cows are not a primary insufficiency of carbohydrate 
metabolism but are likely secondary to disturbances of lipid metabolism (Rukkwamsuk et al., 
1999; Murondoti et al., 2004). The latter conclusion does not change when considering that 
withdrawing high-dose GI led to posttranscriptional downregulation of G6-Pase in the present 
study because the physiological activity of G6-Pase is regulated by the intracellular 
concentration of its substrate (glucose 6-phosphate; Van Schaftingen and Gerin, 2002). The 
decrease in the activity of G6-Pase after stopping glucose infusion could thus be related to an 
increased availability of glucose 6-phosphate if one acknowledges that glucose 6-phosphate 
does not only emerge from gluconeogenesis but also from glycogenolysis (Nordlie et al., 
1999; Van Schaftingen and Gerin, 2002). Since the liver accumulates excess amounts of 





after stopping the infusion could lead to increased availability of glucose 6-phosphate and, 
subsequently, to a reduction in G6-Pase activity. 
 
In conclusion, our study demonstrated that increases of glucose supply have, in general, no 
negative effect on the activity of key gluconeogenesis enzymes in mid-lactating dairy cows. 
Only very high dosages selectively suppress PC mRNA abundance and FBPase activity. Both 
effects were fully reversed within only 4 d after the end of high-dose GI. The latter indicates 
that glucose metabolism is rather robust with regard to changes in glucose supply in either 
direction, at least, in the absence of other metabolic disturbances. 
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A positive energy balance in dairy cows prepartum may decrease hepatic carnitine 
palmitoyltransferase (CPT) enzyme activity, which might contribute to disturbances of lipid 
metabolism postpartum. The purpose of the present study was to investigate whether skeletal 
muscle CPT activity can also be downregulated during positive energy balance. Midlactating 
dairy cows were maintained on intravenous infusion of either saline (control) or glucose 
solutions that increased linearly over 24 d, remained at the 24-d level until d 28, and were 
suspended thereafter. Liver and skeletal muscle biopsies, as well as four diurnal blood 
samples, were taken on days 0, 8, 16, 24, and 32, representing infusion levels equivalent to 
0%, 10%, 20%, 30%, and 0% of the net energy for lactation (NEL) requirement, respectively. 
Glucose infusion increased serum insulin concentrations on d 16 and 24 while plasma glucose 
levels were increased at only a single time point on d 24. Serum beta-hydroxybutyric acid 
(BHBA) concentrations decreased between d 8 and 24; whereas changes in non-esterified 
fatty acids (NEFA) were mostly insignificant. Total lipid contents of liver and skeletal muscle 
were not affected by treatment. Hepatic CPT activity decreased with glucose infusion (by 
35% on d 24) and remained decreased on d 32. Hepatic expression levels of CPT-1A and 
CPT-2 mRNA were not significantly altered but tended to reflect the changes in enzyme 
activity. In contrast to the liver, no effect of glucose infusion was observed on skeletal muscle 
CPT activity. We conclude that suppression of CPT activity by positive energy balance 
appears to be specific for the liver in midlactating dairy cows. 
 






During periods of negative energy balance, such as early lactation, massive mobilization of 
non-esterified fatty acids (NEFA) from adipose tissue is common in high-yielding dairy cows. 
This situation may trigger the development of metabolic disorders like fatty liver and ketosis. 
Fatty liver develops when hepatic import of NEFA exceeds the capacity to oxidize NEFA or 
to export them after re-esterification as very low density lipoproteins (Grummer, 1993; Bobe 
et al., 2004). Consequently, inefficient hepatic β-oxidation of long chain fatty acids (LCFA) 
could be one of the predisposing factors for fatty liver in lactating dairy cows (Emery et al., 
1992; Drackley, 1999; Murondoti et al., 2004). 
 
The β-oxidation of LCFA is localized to mitochondria, and the flux of LCFA into the 
mitochondrial matrix is considered the rate-limiting step for their degradation (McGarry and 
Brown, 1997; Eaton, 2002). This influx step is mediated by the carnitine-acylcarnitine 
translocase system which is composed of the carrier protein, carnitine-acylcarnitine 
translocase, and two mitochondrial carnitine palmitoyltransferases (CPT) (for review see 
McGarry and Brown, 1997; Kerner and Hoppel, 2000). CPT-1 on the outer membrane of 
mitochondria catalyzes the initial reaction of activated LCFA (LCFA-CoA) with carnitine to 
form the transportable substrate, acylcarnitine; while CPT-2 is required to release LCFA-CoA 
from acylcarnitine inside the mitochondrial matrix. The two steps catalyzed by CPT largely 
determine transport rates (McGarry and Brown, 1997; Eaton, 2002). Therefore, the regulation 
of hepatic CPT function is considered an important intervention point for the prevention and 
treatment of lipid-related metabolic disorders in dairy cows (Drackley, 1999). So far, nutrition 
has been acknowledged as a potential intervention strategy because hepatic CPT activity 
increased during negative energy balance (Dann and Drackley, 2005; Douglas et al., 2006) 
and decreased with a high-energy diet (Aiello et al., 1984). 
 
What remained unclear, however, is the responsiveness of CPT in other tissues to changes 
in energy supply. Apart from liver and mammary tissue, only muscle tissue can contribute 
significantly to the oxidation of LCFA, which can be relevant for disorders of lipid 
metabolism. In human and rat, prolonged increases in systemic glucose supply lead to an 
increase in muscle fat content and decreases in muscle CPT activity and fatty acid oxidation 
(Krebs and Roden, 2004; Cahová et al., 2007). These metabolic changes are closely 
associated with the development of insulin resistance, the major factor in the pathogenesis of 





insulin resistence can also be observed in non-lactating cows when excess energy is provided 
during the dry period (Holtenius et al., 2003). If insulin resistance persists into lactation, it 
might contribute to metabolic disorders during the periparturient period (e.g. fatty liver and 
ketosis; Hayirli, 2006). Therefore, possible changes in skeletal muscle CPT activity relative to 
the energy balance could be of relevance for the postpartum health status in dairy cows. To 
elucidate whether CPT of liver and skeletal muscle respond in a co-ordinate manner to 
positive energy balance, their catalytic activities were compared during steadily increasing 
glucose infusions in the present study. 
 
Materials and methods 
Animals, management and experimental design 
The experimental design has been described in detail in an earlier report (Al-Trad et al., 
2009). It utilized procedures pre-approved by the local authorities, the Regierungspräsidium 
Leipzig (reference 24-9168.11, TVV 49/06). In short, twelve midlactating dairy cows (2nd - 
4th month of gestation) were aseptically fitted with a 14-ga, 20-cm jugular catheter (Cavafix 
Certo Splittocan 338, Melsungen, Germany) which was replaced every 8 d. Cows were 
assigned into two groups balanced for actual lactation performance and actual days in milk. 
The saline (n = 6) and glucose infusion groups (n = 6) received continuous jugular infusions 
of 0.9% NaCl and 40% glucose solutions, respectively (both from Serumwerk Bernburg, 
Bernburg, Germany), over a period of 28 d. The glucose infusion dose was calculated for each 
animal separately as a percentage of their daily energy requirement for maintenance and 
lactation (based on net energy for lactation, NEL) according to the recommendations of the 
National Research Council (2001) (see Calculations and Statistical Analysis). To allow for 
day-by-day adaptation to the surplus glucose supply, glucose infusion started at 1.25% of the 
NEL requirement at d 1 and gradually increased by 1.25% each day until a maximum dose of 
30% of the NEL requirement was reached at d 24. This maximum dose equalled to 2.65 ± 0.19 
kg glucose per cow per day. Then the infusion dose was maintained at 30% of the NEL 
requirement until d 28. No infusions were made between d 29 and d 32. The volumes of 
saline infusions were calculated the same way like the volumes of glucose infusions based on 
the NEL requirement of the individual cow. Twice daily (at 0600 h and 1500 h), cows were 
offered a components diet based on grass haylage (60.2% of total dry matter, DM) and a 
concentrate supplement containing a commercial concentrate mix for lactating dairy cows 
(Multilac; 27.2% of total DM; Leikra GmbH, Leipzig, Germany) and soybean meal (12.6% of 





order to minimize the direct entry of glucose from the gastrointestinal tract and, thereby, to 
assess the whole relevant range of surplus glucose supply. This also resulted in a slightly 
negative energy balance when no glucose was infused (see below). The diet contained 6.72 
MJ NEL/kg DM and had the following approximate composition (g/kg DM); crude protein 
202.1, utilizable protein 162.5, ether extract 33.2, crude ash 95.4, acid detergent fibre 231.9, 
neutral detergent fibre 379.0, sugar 43.7, starch 112.6, K 22.1, Na 1.0, Ca 7.6, P 5.0, Mg 2.4. 
Because the cows did not decrease feed intake during glucose infusion, energy balance 
increased in the glucose infusion group from -14.6 to 35.4 MJ/d between d 0 and d 24; while 
it remained unchanged in the saline group during the same period (from -10.4 to -1.8 MJ/d; 
Al-Trad et al., 2009). Cows were milked daily at 0630 and 1600 h. The energy-corrected milk 
yield amounted to 31.5 and 29.4 kg/d in the saline and glucose infusion group, respectively, at 
the start of the experiment (Al-Trad et al., 2009). 
 
Sample collection 
Liver and skeletal muscle biopsies were obtained between 1000 h and 1200 h on d 0, 8, 16, 
24, and 32. Liver biopsies were performed following the procedure of Gröhn and Lindberg 
(1982). Approximately 500 mg of liver tissue was aseptically collected under local anesthesia 
(5ml Isocain 2%, Selectavet, Weyarn-Holzolling, Germany) using a 2.5-mm wide, 25-cm 
long biopsy needle (Model Berlin, Walter Veterinär-Instrumente, Rietzneuendorf, Germany). 
Liver samples were washed immediately in ice-cold saline and one portion (~100 mg) for 
mitochondrial isolation was suspended in ice-cold homogenization buffer containing 20 mM 
4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES), 100 mM sucrose and 0.25 
mM ethylenediaminetetraacetic acid (EDTA), adjusted to pH 7.4 using NaOH. Another 
portion of liver samples (~300 mg) was transferred into tubes with 3 mL RNAlater (Qiagen, 
Germantown, MD) for RNA isolation. The remaining tissue was washed immediately in ice-
cold saline, snap-frozen in liquid nitrogen, and stored at -80 °C for total lipid content analysis. 
Skeletal muscle biopsies were taken after subcutaneous and intramuscular local anesthesia 
under aseptical conditions via a ~ 5 cm scalpel incision over the gluteus medius muscle. 
Incisions for muscle biopsies were made alternating on the left and right side, and were closed 
using a simple continuous suture for muscle and subcutaneous tissue and a Ford interlocking 
suture (Reverdin) for skin closure. For mitochondrial isolation, approximately 500 mg of 
muscle tissue was washed in ice-cold saline and suspended in ice-cold homogenization buffer 





analysis, ~ 200 mg skeletal muscle was washed immediately in ice-cold saline, snap frozen in 
liquid nitrogen, and stored at -80 °C. 
 
To monitor changes of blood metabolites concentrations over the infusion period, blood 
samples were collected via puncture of the coccygeal vein at 1000, 1600, 2200 and 0400 h on 
days 0, 8, 16, 24, and 32 before each biopsy. Tubes with anticoagulant (lithium heparin, 
Sarstedt, Nümbrecht, Germany) were used to obtain plasma for glucose analysis. Tubes with a 
clotting activator (Sarstedt) were used for serum preparation for insulin, β-hydroxybutyric 
acid (BHBA) and NEFA analysis. Heparinized tubes were immediately placed on ice, and 
transported to the laboratory within 30 min after sampling. Plasma was separated from whole 
blood by centrifugation at 4 °C and 3 000 × g for 15 min. Blood tubes without heparin were 
allowed to sit for 30 min at room temperature and centrifuged at room temperature (3 000 × g, 
15 min) to separate serum. All plasma and serum samples were stored at –20°C until further 
analyses. 
 
Analysis of blood metabolites 
Plasma glucose and serum NEFA and BHBA concentrations were assayed on a Hitachi 912 
automatic analyzer (Boehringer Mannheim, Mannheim, Germany) using commercial kits 
obtained from Roche Diagnostics GmbH (Mannheim, Germany) for glucose and from 
Randox Laboratories Ltd. (Crumlin, UK) for NEFA and BHBA measurements. A radiometric 
immunoassay was used for serum insulin analysis, using self-prepared calibration standards. 
The latter were produced by diluting bovine insulin in the human insulin-free serum provided 
with the test (INS-IRMA; BioSource Europe SA, Nivelles, Belgium). 
 
Analysis of CPT activity 
Mitochondria from liver (Mizutani et al., 1999) and skeletal muscle (Power and Newsholme, 
1997) were prepared immediately after the biopsy by differential centrifugation as described 
previously. Mitochondria were stored at -80 °C until analysis. After thawing, CPT activity 
was measured by following the release of CoA-SH from palmitoyl-CoA based on the 
colorimetric procedure described by Bieber et al. (1972). The assay medium comprised in a 
final volume of 0.9 ml: Tris-HCl-DTNB buffer (containing 116 mM Tris HCl, 2 mM EDTA, 
0.25 mM 5,5'-dithiobis-2-nitrobenzoic acid (DTNB), pH 8.0), 0.04 mM palmitoyl-CoA and 
1.25 mM L-carnitine. The reaction was initiated by the addition of 0.1 ml of tissue 





followed at room temperature by monitoring the changes in absorbance at 412 nm on a 
Thermo Scientific EvolutionTM 100 spectrophotometer (Thermo Fisher Scientific, Dreieich, 
Germany), using the molar extinction coefficient for 5-thio-2-nitrobenzoate (TNB; 13,600 M-1 
cm-1) as conversion factor. Control samples without L-carnitine solution were run for each 
sample. The CPT activity was calculated as the difference between the rates in the presence 
and absence of L-carnitine, and expressed as nanomoles of CoA release/min/mg of 
mitochondrial protein under the above assay conditions. Activity of CPT was normalized to 
mitochondrial protein contents which were determined by the protein assay method of Smith 
et al. (1985). 
 
Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) 
RNA was extracted from liver tissues using Trizol reagent (Invitrogen, Carlsbad, CA) 
according to the manufacturer's instructions. The quantity of RNA was determined by 
measuring the absorbance at 260 nm and purity was determined by measuring the A260/A280 
ratio which was > 1.85 for all preparations. Integrity of RNA was assessed by agarose gel 
electrophoresis. Total RNA (1 µg) was reverse transcribed using oligo-d(T)15 primer in a 20-
µl reaction according to the manufacturer's instructions (AMV-RT kit, Roche Diagnostics, 
Mannheim, Germany).  
 
A comparative analysis of hepatic CPT-1A and CPT-2 mRNA levels between treatment 
and control groups was carried out by qRT-PCR using β2-microglobulin (B2M) as 
unregulated reference gene. PCR primers and dual-labelled fluorescent probes were designed 
using the web-based quantitative PCR probe design software provided by MWG Biotech AG 
(Ebersberg, Germany; http://www.eurofinsdna.com) and synthesized by the same company. 
Since no sequence information was available for bovine hepatic CPT-1A at the time of 
analysis, a primer set derived from the ovine sequence (GenBank accession Y18387.1; 
forward primer: 5′-ATG ACG GCT CTG GCA CAA GA-3′; reverse primer: 5′-TGG ATG 
GTG TCT GTC TCC TC-3′  was applied first to amplify and sequence a respective bovine 
cDNA fragment. This unique bovine CPT-1A sequence was submitted to GenBank 
(FJ415874) and used for the selection of primers and probes in the qRT-PCR experiments. 
GenBank accession numbers and the derived primers and probes for qRT-PCR were as 
follows: B2M (GenBank BC118352.1; forward primer: 5′-AGC GTC CTC CAA AGA TTC 
AAG T-3′; reverse primer: 5′-GGA TGG AAC CCA TAC ACA TAG CA-3′; probe: 5′-FAM–





FJ415874.1; forward primer: 5′-CTG GAC CGG GAG GAA ATC-3′; reverse primer: 5′-CCG 
AGA AGT ATT AAA CAT GCG C-3′; probe: 5′-ROX-TTC TGG GGT CTA CGA TTC 
CGC TCT GCT-BHQ2-3′), and CPT-2 (GenBank BC105423.1; forward primer: 5′-TGT 
GAG TGC CTC TGA AAT CC-3′; reverse primer: 5′-CAC TAG TCA GAT ACG AAA 
GCG G-3′; probe: 5′-JOE-TAC ATT CTG TCA GAC AAT AGC CCG GCC C-TAM-3′). To 
ensure the specificity of the primers and probes, an ethidium-bromide stained agarose gel 
(1%) was run in which a single band of expected molecular size was obtained. 
 
RNA quantification by qRT-PCR was carried out using Rotor-Gene 6000 (Corbett 
Research, Sydney, Australia). For each sample, the target gene and the control gene were run 
under duplex reaction conditions in duplicate. The following reagents were used for 
amplification in 20 μl final volume: 1 μl of sample cDNA, 2μl Mg-free 10X buffer, 0.75 U 
Dynazyme II DNA polymerase (Finnzymes, Finland), 5.5 mM MgCl2, 0.3 mM dNTP, 
900 nM of each primer and 150 nM of each probe for CPT-1A and CPT-2, 200 nM of each 
primer and 50 nM of each probe for B2M. Amplification conditions for quantification were: 
95 °C for 2 min and 45 cycles of 95 °C for 30 s, 55 °C for 30 s and 72 °C for 30 s. After the 
amplification efficiency of each target and reference gene was validated, the relative gene 
expression levels were determined by the 2-ΔΔCT method as described by Livak and 
Schmittgen (2001). With this method, levels of genes expression were normalized to B2M 
and expressed as relative values using a single sample obtained from one cow in the saline 
treatment group at d 0 as an interplate calibrator. 
 
Liver and skeletal muscle total lipid content 
Samples of frozen liver and skeletal muscle were analyzed for concentrations of total lipid by 
the gravimetric method after chloroform-methanol extraction (Floch et al., 1957). 
 
Calculations and statistical analyses  
Net energy required for maintenance and lactation (MJ/day) was calculated as 4.184 × 
([BW0.75 × 0.08] + milk yield (kg) × [(0.0929 × fat %) + (0.0563 × true protein %) + (0.0395 × 
lactose %)]) according to the NRC (2001). Based on the energy requirement, infusion dose 
(kg glucose/day) was calculated as follows; designated dose level × NEL/(15.6 MJ/kg).  
 
Statistical analyses were conducted using the Sigma Stat software package (version 3.5; 





ANOVA followed by Dunnett's post hoc analysis. In cases of non-normal distribution of the 
data, the Friedman repeated-measures ANOVA on ranks, followed by Dunnett's test, was 
used. Results were considered statistically significant when P < 0.05. 
 
Results 
Plasma glucose concentrations remained in the physiological range without significant diurnal 
variations when glucose infusion doses varied between 0 - 20% NEL requirements (i.e. from d 
0 to d 16; P > 0.05; Fig. 1). A period of marked hyperglycaemia was only observed at the 
highest infusion dose (30% NEL requirement) on day 24. This single period occurred at 1600 
h, i.e. 1 h postprandially. Increases in serum insulin concentration were observed initially at 
night time on d 16 (2200 h and 0400 h; P < 0.01; Fig. 2) but extended to the afternoon (1600 
h; P < 0.01) when glucose infusion increased to 30% NEL requirement on day 24. 
 
Serum BHBA levels started to decrease by glucose infusion already on d 8 between 1600 h 
and 0400 h (P < 0.05), and were lower than initial values at all day times on d 16 and d 24 in 
the glucose infusion group (P < 0.01; Fig. 3). A similar trend for glucose-induced decreases in 
serum concentration was also observed for NEFA; but this numerical decrease reached 
statistical significance (P < 0.05) only for a single time point (2200 h) on d 16 (Fig. 4). 
 
The activity of hepatic CPT decreased by 35% when glucose dose increased from 0% to 
30% NEL requirement between d 0 and d 24 (P < 0.01; Table 1). This depression in hepatic 
CPT activity persisted until four days after the end of the infusion period (d 32; P < 0.01, 
Table 1). In contrast to the liver, no effect of glucose infusion was observed on skeletal 
muscle CPT activity (P > 0.1; Table 1). 
 
To elucidate whether the decrease in the hepatic CPT activity during glucose infusion was 
due to downregulation of CPT gene transcription, the mRNA expression of the two hepatic 
CPT isoforms, CPT-1A and CPT-2, was measured by qRT-PCR. These analyses revealed 
numerical decreases in the mRNA abundance of CPT-1A (by 28%) and CPT-2 (by 42%) that 
were comparable to the glucose-induced decrease in hepatic CPT activity (35%); but none of 
the decreases in mRNA abundance reached statistical significance (P > 0.1; Table 1). No 
attempt was made to measure the gene expression level of muscular CPT (i.e. CPT-1B and 
CPT-2) given the unchanged enzyme activity of CPT in skeletal muscle. No significant 








































































Figure 1.  Mean plasma glucose 
concentrations for blood samples taken the 
day before each biopsy at 1000 h, 1600 h, 
2200 h, and 0400 h for cows treated with 
glucose (■) or saline (●). 
Open symbols depict post-infusion values. 
Data are expressed as means ± SEM. *P < 
0.05 vs. day 0. 






















































Figure 2.  Mean serum insulin concentrations 
for blood samples taken before each biopsy at 
1000 h, 1600 h, 2200 h, and 0400 h for cows 
treated with glucose (■) or saline (●). 
Open symbols depict post-infusion values. 
Data are expressed as means ± SEM. **P < 




















































































Figure 3.  Mean serum concentrations of 
beta-hydroxybutyric acid (BHBA) for blood 
samples taken before each biopsy at 1000 h, 
1600 h, 2200 h, and 0400 h for cows treated 
with glucose (■) or saline (●). 
Open symbols depict post-infusion values. 
Data are expressed as means ± SEM.  */**P < 
0.05/0.01 vs. day 0. 
 


























































Figure 4.  Mean serum concentrations of 
non-esterified fatty acid (NEFA) for blood 
samples taken before each biopsy at 1000 h, 
1600 h, 2200 h, and 0400 h for cows treated 
with glucose (■) or saline (●). 
Open symbols depict post-infusion values. 
Data are expressed as means ± SEM. *P < 






Table 1. Liver and skeletal muscle CPT activity, expression levels of hepatic CPT-1A and CPT-2 mRNA, and total lipid  













CPT Activity  (nmol/min/mg mitochondrial protein)  
Glucose 29.9 28.0 24.0 19.6** 18.3** 
Liver 
Saline 26.3 24.7 21.9 22.0 25.0 
2.4 
Glucose 6.9 7.2 6.7 6.3 7.0 
Skeletal muscle  
Saline 7.6 7.5 8.1 6.6 7.4 
1.6 
relative mRNA expression1  2−ΔΔCT  
Glucose 0.71 0.65 0.44 0.51 0.57 
Hepatic CPT-1A 
Saline 0.52 0.70 0.38 0.60 0.61 
0.13 
Glucose 0.63 0.63 0.55 0.37 0.70 
Hepatic CPT-2 
Saline 0.67 0.47 0.49 0.58 0.75 
0.12 
Total Lipid  (% wet weight)  
Glucose 3.55 3.77 3.73 4.64 4.35 
Liver 
Saline 3.50 4.05 3.61 3.43 3.60 
0.24 
Glucose 3.62 3.62 3.18 4.09 3.27 
Skeletal muscle 
Saline 3.04 3.90 3.63 3.17 3.22 
0.22 
1Data are expressed as means with pooled SEM. **P < 0.01 vs. day 0. 1Data are expressed as the normalized ratio of gene expression  






The present study was intended to provide insight into the responses of liver and skeletal 
muscle CPT activity to gradual increases in glucose availability, brought by intravenous 
glucose infusion in lactating dairy cows. To assess the concurrent changes in metabolism, 
blood concentrations of glucose, insulin, BHBA and NEFA were simultaneously monitored. 
The latter analyses revealed a continuous increase in serum insulin concentration with 
increasing glucose infusions, while plasma glucose concentrations were only elevated in 
postprandial blood samples during the highest infusion dose. When considering that the 
maximum amount of postruminal digestible starch has been estimated with ~2 kg/d in dairy 
cows (Matthé et al., 2001; Gäbel and Aschenbach, 2004), it might not be surprising that a 
glucose dose of ~1.8 kg/d (i.e. 20% NEL requirement) was tolerated by the cows of the 
present study while a dose of 2.6 kg/d (i.e. 30% NEL requirement) led to hyperglycaemia. The 
occurrence of temporal hyperglycaemia on d 24 thus indicates that we explored the whole 
relevant dose range of surplus glucose supply. On the other hand, an observed trend for 
decreases in serum NEFA concentration indicates that glucose infusion interacted with lipid 
metabolism, likely via an insulin-mediated inhibition of fatty acid mobilization from adipose 
tissue (Vernon, 1980). That decreases in serum NEFA concentration reached statistical 
significance only at a single time point on d 16 becomes plausible if one considers that the 
decrease in adipose tissue lipid release during glucose infusion is generally paralleled by a 
decrease in lipid oxidation (Treacher et al., 1976). With regard to the liver, such decreased 
fatty acid oxidation was evident from the decreased serum BHBA concentrations as will be 
discussed in more detail below. 
 
In many species, it has been well established that the main regulatory step of fatty acid 
oxidation is CPT-1 (Aiello et al., 1984; McGarry, 1998; Bonnefont et al., 2004; Morash et al., 
2008). In fatty acid synthesizing tissues like liver, short-term regulation of CPT-1 is inversely 
coupled to the endogenous production of fatty acids; which is based on an allosteric inhibition 
of CPT-1 by the first metabolite of de novo fatty acid synthesis, malonyl-CoA (Bonnefont et 
al., 2004; Morash et al., 2008). Tissues without fatty acid synthesizing capacity, like skeletal 
muscle, are yet able to perform this first step of fatty acid synthesis and specifically produce 
malonyl-CoA as a signaling molecule to inhibit CPT-1 short-term (McGarry, 1998). 
Intermediate to long-term regulation of CPT-1 activity is primarily transcriptional (McGarry 
and Brown, 1997) but can also involve changes in mitochondrial membrane fluidity. Such 





sensitivity (Kolodziej and Zammit, 1990) and are likely the pathway by which insulin 
increases the malonyl-CoA sensitivity of CPT-1 and down-regulates fatty acid oxidation 
(Zammit, 1999). In contrast to the well defined role of CPT-1, the role of CPT-2 in the 
regulation of fatty acid oxidation is less clear. CPT-2 is insensitive to short-term regulation by 
malonyl-CoA (Declercq et al., 1987), less dependent on membrane-enzyme interaction than 
CPT-1 (Declercq et al., 1987; Woeltje et al., 1987), and had been rather stably expressed at 
different ontogenetic and metabolic states during previous studies in rats (Bonnefont et al., 
2004). 
 
The enzyme activity assay applied in the present study measures the intermediate to long-
term regulation of total CPT activity. This intermediate to long-term regulation sets the 
margins within the animal can respond to changing metabolic demands. The freeze-thawing 
step of our protocol partly damages mitochondrial membranes and thus allowed for combined 
analyses of CPT-1 activity localised to the outer and CPT-2 activity localized to the inner 
mitochondrial membrane (Woeltje et al., 1987). The results obtained with this method showed 
that glucose load had a regulatory effect on only hepatic but not skeletal muscle CPT activity. 
The intermediate to long-term character of the depressive effect on hepatic CPT activity was 
evident from its persistence for four days after stopping the surplus glucose supply (i.e. until d 
32). 
 
As regards the cause of glucose-induced depression of hepatic CPT activity, the elevation 
in serum insulin level observed between d 16 and d 24 may provide one possible explanation. 
As discussed above, insulin has been suggested to increase the malonyl-CoA sensitivity of 
CPT-1 via a modification of the mitochondrial membrane fluidity (Zammit, 1999), which 
could implement a decrease in baseline enzyme activity, too (Morash et al., 2008). On the 
other hand, transcriptional regulation likely also contributed to the decreased hepatic CPT 
activity. Unfortunately, the performed qRT-PCR experiments faild to provide statistical proof 
for this. Nevertheless, qRT-PCR revealed numerical decreases in the hepatic expression of 
both CPT-1A (by 28 %) and CPT-2 (by 42%), which were in the same range like the observed 
decrease in enzyme activity (by 35%) between d 0 and d 24. 
 
Our finding of decreased hepatic CPT activity with possibly transcriptional causes after 
surplus energy supply is in agreement with previous studies showing increased CPT activity 





2006). Although one might expect that skeletal muscle CPT would be affected in a similar 
manner by energy balance, the missing effect of glucose infusion on skeletal muscle CPT 
seems to be compatible with metabolic priorities in the high-yielding dairy cow. 
 
The transition of dairy cows from a positive energy balance prepartum to a negative energy 
balance postpartum requires mobilization of body fat reserves, evidenced by a rise of NEFA 
concentration in blood plasma (Bell, 1995; Vernon, 2005). Besides the mammary gland where 
NEFA are predominantly used for milk fat synthesis (Bell, 1995), liver and skeletal muscle 
are major NEFA-utilizing tissues (Heitmann et al., 1987; Hocquette and Bauchart, 1999; 
Drackley et al., 2001). Skeletal muscle differs from liver because it utilizes NEFA exclusively 
for its own energy metabolism. By contrast, liver clears NEFA from the systemic circulation 
in excess of its own demand. It converts part of them to water-soluble ketone bodies (e.g. 
BHBA and acetoacetate) that can be used as energy substrates by other tissues (Heitmann et 
al., 1987; Emery et al., 1992; Drackley et al., 2001), and re-esterifies the remaining part to 
triglycerides (Hocquette and Bauchart, 1999; Drackley et al., 2001). The hepatic conversion 
of NEFA to ketone bodies includes mitochondrial β-oxidation of the imported LCFA as an 
essential step (Kerner and Hoppel, 2000; Drackley et al., 2001; Vernon, 2005). Thereby, 
hepatic fatty acid oxidation plays a key role not only for the control of blood NEFA levels but 
also for the provision of adequate amounts of ketone bodies. From a teleological point of 
view, it appears thus plausible that hepatic fatty acid oxidation has a higher metabolic priority 
for regulation and requires larger plasticity compared to fatty acid oxidation in skeletal 
muscle. 
 
The intracellular level of fatty acids itself appears to be the prevailing signal for the 
metabolic regulation of CPT activity. Their effect is essentially mediated via peroxisome 
proliferator-activated receptor (PPAR)-α as has been shown for CPT-1B in murine 
cardiomyocytes (Brandt et al., 1998). A higher functional activity of PPAR-α in liver 
compared to skeletal muscle would thus provide a plausible hypothesis for the negative effect 
of glucose infusion on hepatic but not skeletal muscle CPT activity. Indeed, a recent study by 
Waters et al. (2009) failed to detect an involvement of PPAR-α in the regulation of Δ9-
desaturase in beef muscle, which could point to a low activity of PPAR-α in beef muscle 
tissue. However, more studies are warranted to test the applicability of the above hypothesis 





It should finally be noted that a low level of CPT regulation in skeletal muscle could 
contribute to the development of peripheral insulin resistance in the postpartum dairy cow. 
Failure to upregulate CPT activity in muscle with increasing availability of NEFA during 
times of negative energy balance would promote the accumulation of intracellular lipids. It 
has been shown in other species that such accumulation of intracellular lipids leads to insulin 
resistance (Krebs and Roden, 2004) due to suppression of insulin signalling (Cahová et al., 
2007). Albeit muscle tissue may appear to have a minor share in energy partitioning during 
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6 General Discussion 
Although infusions into the stomach or intestine would be a more physiological route of 
glucose entry, such studies are biased by the high utilization of glucose within the portal-
drained viscera (REYNOLDS et al. 1994) and may further be biased by the release of 
gastrointestinal hormones that affect glucose metabolism and food intake (e.g. glucagon-like 
peptide-1; HOLST 2007). Therefore, the effect of glucose dose at the level of intermediary 
metabolism can only be assessed by using an intravenous infusion route like in the present 
study. The dose of infused glucose was increased slowly and gradually from 0% of NEL 
requirement at d 0 to 30% at d 24 (i.e. to 2.65 ± 0.19 kg glucose per cow at d 24). In addition 
to testing the dose effect of surplus glucose, this gradual infusion protocol proofed to be 
advantageous in several aspects. The most important advantage is probably that the 
potentially confounding effects occasionally observed in constant level infusion protocols, 
such as decreased DMI and fall in the blood phosphorus concentration (hypophosphatemia), 
could be avoided (DHIMAN et al. 1993; GRÜNBERG et al. 2006). In the present study, 
hypercaloric intravenous GI did not affect feed intake even when the infusion dose amounted 
to 2.65 kg glucose per day (Chapter 3, Table 2). Consequently, when interpreting data, the 
infused glucose can be considered true surplus supply of glucose and energy as indicated by 
the increase in the energy balance status of GI cows (Chapter 3, Table 2). A minimal direct 
entry of glucose from feed can be expected because the diet was low in starch and sugar 
(Chapter 3, Table 1). Based on this minimal direct entry at the beginning of the infusion 
period, glucose supply was gradually increased until hyperglycemia, hyperinsulinemia and 
glucosuria were evident at the end of the infusion period. Consequently, the infusion protocol 
explored the entire range of nutritionally relevant surplus glucose. 
 
6.1 Glucose Supply Is Not a Limiting Factor for Lactation Performance in Midlactating 
Dairy Cows 
Effects of excessive glucose supply on milk yield and components have attracted considerable 
attention in dairy cows. Regarding results obtained from a number of previous studies 
conducted in lactating dairy cows, responses of milk yield to an exogenous glucose supply 
were inconclusive (KNOWLTON et al. 1998; HURTAUD et al. 2000). The present finding 
that excessive glucose supply had no effect on milk yield (Chapter 3, Table 2) is in agreement 
with a number of previous studies in which intravenous (AMARAL et al. 1990; KIM et al. 
2000) or postruminal GI (CLARK et al. 1977; LEMOSQUET et al. 1997) did not 





could support the hypothesis that the failure of GI to enhance milk production could be 
independent of the route of glucose administration. In contrast to the present study, however, 
a previous study by RIGOUT et al. (2002b) had observed dose effects of duodenal GI on milk 
yield. Since the present study using increasing doses of intravenous glucose did not show the 
same effect, it seems appropriate to conclude that the metabolic fate of glucose, including its 
conversion to milk lactose, may be modified by metabolic and/or hormonal signals from the 
portal-drained viscera when absorbed from the intestine. 
 
Milk lactose is considered the primary osmoregulator of milk (LINZELL and PEAKER 
1971; RIGOUT et al. 2002b); hence, an increase in glucose availability for mammary gland 
lactose synthesis could be a mechanism for increased milk yield during additional glucose 
supply (KNOWLTON et al. 1998; RIGOUT et al. 2002b). In the present study, the missing 
effects of GI on milk lactose yield (Chapter 3, Table 2) might be a plausible explanation for 
the absent effect of glucose supply on milk yield. It is noteworthy that the present study was 
conducted over a long time period and the infusion dose was gradually increased over time. 
Therefore, it can be assumed that the gradual increases in the glucose doses with a long-term 
infusion period play a potential role in enhancing metabolic and/or hormonal adaptation 
mechanisms to the excessive glucose supply (REYNOLDS et al. 1994; KNOWLTON et al. 
1998) and, as a consequence, tissues glucose storage and/or utilization rate increased without 
affecting mammary gland glucose uptake and metabolism. This assumption of day-by-day 
adaptation is supported, in part, by the sudden decrease in milk lactose output after glucose 
withdrawal (Chapter 3, Table 2). 
 
Previous studies showed a negative effect of GI on milk fat yield (FISHER and ELLIOT 
1966; HURTAUD et al. 2000) which was related to the decrease in blood precursors for milk 
fat synthesis (acetate, BHBA, and NEFA; MCCLYMONT and VALLANCE 1962). 
Unfortunately, a similar depression in milk fat yield could neither be proofed nor disproofed 
in the present study, mainly because a decrease in milk fat percentage and yield occurred also 
in the SI group (Chapter 3, Table 2). It is likely, however, that the differences in serum 
concentrations of NEFA, and BHBA (serum acetate was not measured) might have been too 
small to induce significant changes in milk fat percentage between the two treatments. On the 
other hand, it appears that an increase in energy input by high-dose GI enhanced milk protein 
synthesis (Chapter 3, Table 2). This result is in agreement with the almost consistent increase 





(AMARAL et al. 1990; RULQUIN et al. 2004). The decreases in serum BUN and in the gene 
expression of the key enzyme involved in hepatic glucose synthesis from glucogenic AA (i.e. 
PC, as outlined below) support the concept that the increase in protein synthesis in the 
mammary gland might have been due to the sparing effect of excessive glucose on AA 
breakdown, particularly on glucogenic AA breakdown (REYLONDS et al. 1994; 
VANHATALO et al. 2003). In addition, hormonal effects of increased insulin concentration 
on mammary gland AA uptake could also have contributed to the increase in milk protein 
yield (MACKLE et al. 2000). However, the increase in milk protein yield observed in this 
experiment is still not of practical significance in view of the large amount of infused glucose 
(> 2kg/day) needed to obtain this effect. 
 
Presupposing that the diet offered in this study provided minimal direct entry of glucose 
from the portal-drained viscera (Chapter 3, Table 1), it follows that endogenous glucose 
output from the liver was sufficient to fully meet the demands of milk synthesis already in the 
absence of GI. This further allows the conclusion that glucose availability can hardly be a 
limiting factor for milk yield and milk energy output in mid lactating dairy cows if energy and 
protein requirements are met. Consequently, dairy cows on an energy-balanced diet and 
sufficient protein supply do not direct excess glucose to increased lactation performance. 
 
6.2 Dysregulation of Blood Glucose Occurs Postprandially at High Glucose Loads 
The effect of GI on blood glucose and insulin concentrations was more obvious in the daily 
mean values of blood samples collected every 8 d compared with blood samples collected at 
1000 h every 2 d. Indeed, frequent blood samples (i.e. day profiles) might be necessary to 
detect transient increases in blood glucose and insulin concentrations in response to GI in 
dairy cows. Blood samples collected at 1000 h every 2 d showed a treatment effect on insulin 
concentration and a quadratic day × treatment interaction on both glucose and insulin 
concentrations (Chapter 4, Fig. 1A and B). Nevertheless, the blood glucose and insulin 
concentrations largely remained within the physiological range in the GI-treated group with 
only occasional increases. Further, the daily minimum values of glucose and insulin 
concentrations showed no treatment effects and no significant treatment × dose interactions 
(Chapter 3, Table 3), indicating that daytimes with almost balanced glucose homeostasis 
occurred still when glucose was infused at the highest dose level of 30% NEL requirement. 
Since glucosuria was not present up to an infusion dose of 20% NEL requirements and the 





increase in glucose uptake and storage by peripheral tissues, such as liver, skeletal muscle and 
adipose tissue might enable the cows to deal with the excess supply of glucose in order to 
maintain glucose homeostasis (see Section 6.6.). 
 
At day 24 and with a GI accounting for 30% NEL requirements, the daily maximum values 
of plasma glucose increased by 130% and the maximum serum insulin concentrations 
increased 17-fold (Chapter 3, Table 3) which led to a significant linear treatment effect and 
treatment × day interaction in the daily mean values recorded every 8 d for both glucose and 
insulin concentrations (Chapter 3, Fig. 1A and 1B). In fact, these increases were not constant 
during the day but mostly due to the postprandial hyperglycemia and hyperinsulinemia 
observed in four out of six GI cows (i.e. at 1600 h on d 24; Chapter 5, Fig. 1 and Fig. 2). 
Alterations in peripheral insulin sensitivity may have been responsible for the observed 
postprandial hyperglycemia and hyperinsulinemia as will be discussed in the next section. In 
conclusion, surplus glucose between 0-20% NEL requirements was well tolerated by the cows 
of the present study. The latter would be equivalent to the maximum capacity for postruminal 
starch digestion and absorption (i.e. ~2 kg/d; GÄBEL and ASCHENBACH 2004). Increasing 
the infusion dose from 20 to 30% NEL requirement was no longer tolerated by the animal and 
led to periods of obviously dysregulated glucose homeostasis. 
 
6.3 Gradual Increases in Glucose Supply Cause Insulin Resistance in a Dose-Dependent 
Fashion 
As mentioned above, glucose homeostasis was impaired in GI cows only at high infusion 
doses of 30% NEL requirement as indicated by the postprandial hyperglycemia/ 
hyperinsulinemia. Glucosuria was also detected at the same period in GI cows. To test 
whether these metabolic changes are a consequence to peripheral insulin resistance 
(HOSTETTLER-ALLEN et al. 1994), RQUICKI was calculated in the present study from the 
plasma concentration of glucose, and the serum concentrations of insulin and NEFA 
(Chapter 3, Calculations and Statistical Analysis). RQUICKI has been used mainly in humans 
as a measure for peripheral insulin sensitivity, with lower values being indicative of decreased 
insulin sensitivity (PERSEGHIN et al. 2001; RABASA-LHORET et al. 2003). Recently 
RQUICKI has been introduced as a suitable monitor for insulin resistance in dairy cows since 
glucose tolerance tests are difficult to perform and to interpret in adult ruminants due to 
continuing ruminal fermentation and due to high rates of insulin-insensitive glucose uptake 





interaction was observed for RQUICKI based on a dose-dependent decrease in the index 
value when the infusion dose increased from 0 to 30% NEL requirements (Chapter 3, Fig. 1C). 
Decreased insulin sensitivity in the present study was associated with a plateau in liver 
glycogen content between d 8 and d 16 (Chapter 3, Fig. 3A). The latter indicate that the 
hepatic uptake of glucose and its conversion to glycogen started to become compromised at 
the time when insulin resistance developed. It may appear contradictory that muscle glycogen 
stores also increased in the present study despite insulin resistance (Chapter 3, Fig. 3B). 
However, ruminant animals differ from most non-ruminant species in that they express high 
levels of GLUT1 in their skeletal muscle which is constitutively present and does not require 
insulin stimulation (DUHLMEIER et al. 2005). Thereby, hyperglycemia alone is sufficient to 
increase glucose entry (and glycogen storage) in skeletal muscle. Nonetheless, the ability of 
hyperglycemia to compensate for insulin resistance has also been observed in muscle of 
humans and rats under hyperglycemic, hyperinsulinemic conditions (COMMERFORD et al. 
2001). The decrease in insulin sensitivity might be related to the increase in body weight 
found in GI cow (Chapter 3, Table 2), since insulin sensitivity is disturbed in obese cows 
(HOLTENIUS and HOLTENIUS 2007). However, insulin sensitivity was restored in the 
current study within only 4 days of glucose withdrawal as demonstrated by complete reversal 
of both RQUICKI and liver glycogen content. 
 
6.4 Nutritionally Relevant Increases of Glucose Supply Have No Negative Effect on the 
Enzymatic Capacity for Gluconeogenesis  
To test whether there was a decrease in the enzymatic capacity for hepatic gluconeogenesis in 
GI cows corresponding to the increase in glucose utilization and storage, the effect of 
increasing intravenous GI on the activities and relative mRNA expressions of four rate-
limiting gluconeogenesis enzymes was investigated, namely PEPCK, PC, FBPase and G6-
Pase  (Chapter 4, Table 2). PEPCK has been proposed as the rate-determining enzyme 
involved in hepatic glucose production from propionate in dairy cows (GREENFIELD et al. 
2000). Despite the increase in glucose availability in the present study, the total PEPCK 
activity and the relative mRNA expression levels of its two isoforms (PEPCK-C and PEPCK-
M) showed no dose × treatment interaction, suggesting that infused glucose did not affect 
hepatic capacity for glucose synthesis from propionate. This result supports the view that the 
liver of dairy cows has a high metabolic priority to utilize propionate for gluconeogenesis 





Between infusion doses of 0-20% NEL requirement, the effect of glucose supply on the 
other gluconeogenic enzymes activities and mRNA expressions was very moderate (Chapter 
4, Table 2). However, at non-physiologically high levels of surplus glucose supply (i.e. 
infusion of 30% NEL requirement), a treatment × dose interaction was noted for PC relative 
mRNA expression with a numerical decrease in PC activity (linear treatment × dose 
interaction, P = 0.13). This finding is consistent with previous reports where PC mRNA 
expression is most consistently changed with changing levels of glucose or energy supply in 
ruminants (BRADFORD and ALLEN 2005; LOOR et al. 2006). Lactate and some of the 
glucogenic AA are metabolized first to pyruvate and then directly to OAA through an ATP-
dependent reaction catalyzed by PC. Therefore, the decrease in PC mRNA level with non-
physiologically high glucose loads might mirror a decrease in hepatic gluconeogenic capacity 
from lactate and glucogenic AA. A decreased gluconeogenesis from AA would be expected to 
decrease hepatic urea production which was demonstrated in the present study by the 
decreased serum BUN concentration in the GI group (Chapter 4, Fig. 2A). 
A part of the decrease in PC mRNA level in the present study can be explained by the 
increases in insulin concentrations during the period of high glucose load, mainly, the 
observed postprandial hyperinsulinemia (JITRAPAKDEE and WALLACE 1999). PC activity 
requires acetyl-CoA as an activator. Therefore, the activity of this enzyme is enhanced under 
condition of high fatty acid oxidation, presumably, as a result of increased intramitochondrial 
levels of acetyl-CoA (TUTWILER and DELLEVIGNE 1979). In contrast, reduced rates of 
fatty acid β-oxidation are thought to inhibit hepatic gluconeogenesis by lowering PC activity 
(TUTWILER and DELLEVIGNE 1979; CHOW and JESSE 1992). Previous studies have 
reported that insulin depressed the hepatic capacity for LCFA oxidation (JESSE et al. 1986a; 
ANDERSEN et al. 2002). It may be speculated, therefore, that the observed decrease in PC 
enzyme activity in the present study, although not statistically significant, might have been a 
result of the increased plasma insulin concentration, leading to decreased hepatic fatty acid β-
oxidation as will be discussed in Section 6.8.  
The second enzyme activity significantly affected by GI was FBPase but only at the 
highest dose of infused glucose and with only posttranscriptional downregulation (Chapter 4, 
Table 2). FBPase is postulated to be a key regulatory enzyme that controls the overall output 
of gluconeogenesis (ENGELKING 2004; PILKIS et al. 1988). Consequently, the decrease in 
FBPase activity might represent one of the homeostatic mechanism that is partially able to 





activity could be directly related to the hyperglycemia because excess glucose, together with 
insulin, stimulates the intracellular accumulation of fructose 2,6-bisphosphate, which is a 
powerful competitive inhibitor of FBPase (PILKIS et al. 1988). Additionally, a rapid 
proteasomal degradation of FBPase has been demonstrated in yeast upon exposure to glucose 
(BROWN and CHIANG 2009). The rapid translocation of FBPase to the nucleus observed in 
cultured rat hepatocytes after addition of glucose or insulin (YÁÑEZ et al. 2004) could 
indicate that similar proteasomal degradation of FBPase is possible in the mammalian liver 
during hyperglycemia. 
The aforementioned changes in PC mRNA expression and FBPase activity were fully 
restored within only four days after withdrawing GI as will be discussed in Section 6.9. 
However, posttranscriptional downregulation of G6-Pase activity was observed in the present 
study after withdrawing high-dose GI. This decrease in the activity of G6-Pase could be 
related to the increased intracellular availability of its substrate (i.e. glucose 6-phosphate) 
derived from glycogen breakdown after stopping GI (VAN SCHAFTINGEN and GERIN 
2002). In conclusion, moderate increases of glucose supply (i.e. nutritionally relevant 
increases) have no negative effect on the activity and mRNA expression of key 
gluconeogenesis enzymes in mid-lactating dairy cows. Only high, non-nutritionally relevant 
increases of glucose supply which lead to hyperglycemia and hyperinsulinemia affect some of 
the hepatic gluconeogenesis enzymes (i.e. PC, FBPase). 
6.5 Excessive Glucose Has a Protein-Sparing Effect 
Quadratic day × treatment interaction was detected for the serum BUN concentration from 2-
d blood samples (Chapter 4, Fig. 2A). In addition, the daily minimum, maximum, and AUC 
values for BUN showed numerically larger decreases in GI cows compared to SI cows 
(Chapter 3, Table 3), indicating a protein-sparing effect. A similar response with a decrease of 
BUN concentration has been described earlier during GI studies (VIK-MO et al. 1974; 
OBITSU et al. 2000). The decrease in BUN in the GI group was probably a reflection of the 
improvement of body nitrogen retention through a decrease in the hepatic uptake and 
deamination of glucogenic AA. This has likely promoted the cellular uptake of AA for protein 
synthesis and, as a consequence, led to decreased hepatic urea synthesis (OBITSU et al. 
2000). In the present experiment, the shuttle of AA from hepatic gluconeogenesis pathway to 
protein synthesis pathways is supported by the increase in milk protein output (see Section 






6.6 Surplus Glucose Is Used Mainly by Glycogen and Fat Synthesis Pathways  
Accelerated glucose storage as glycogen (liver and skeletal muscle) and TAG (adipose 
tissues) are the generalized responses to the excessive glucose supply in the current study. It 
had previously been demonstrated in other studies that glucose uptake and utilization by body 
tissues was accelerated with increased glucose supply in dairy cows (AMARAL et al. 1990; 
RIGOUT et al. 2002b). The same effect was also observed in the case of abomasal starch 
infusion (KNOWLTON et al. 1998). As the supply of energy increased by hypercaloric GI in 
the present study, GI cows moved into a positive energy status, stored excess energy as fat, 
and gained BW (Chapter 3, Table 2). The increase in BFT observed in the present study 
supports the view that the increase in BW was in large part due to an increase in adiposity. In 
line with that, previous estimation indicates that each 1-mm changes in the BFT equates 
approximately 5 kg changes in total body fat content (SCHRÖDER and STAUFENBIEL 
2006). If this estimation is applied to the results of the present study, then it can be calculated 
that ~78% of the increases in the BW came from the increase in body fat depositions. This 
assumption is supported by the observations that lipogenesis from glucose and other 
substrates (acetate, lactate) is enhanced in times of increased glucose availability in ruminants 
(BALLARD et al. 1972; VERNON 1980). Additionally, a very small fraction of the observed 
BW gain was also attributable to glycogen storage in liver and skeletal muscle (Chapter 3, 
Fig. 3). Over all, the increase in BW, BFT and the capacity of liver and skeletal muscle to 
accumulate glycogen in the present study, coupled with a decrease in intermediate lipid and 
protein metabolism, all suggest that the rate of glucose uptake and utilization by peripheral 
tissues was increased with increased glucose supply. 
 
6.7 Surplus Glucose Diverts Lipid from Energy-Generating Pathways into Anabolic     
Pathways 
Significant dose × treatment interaction was present for the minimum values of serum NEFA 
concentrations (Chapter 3, Table 3) and a trend toward a treatment × quadratic dose 
interaction was observed for serum NEFA concentrations measured in 2-d blood samples 
(Chapter 4, Fig. 3C), indicating a decrease in the mobilization of body fat and an improved 
EB status for GI cows. Similarly, daily mean (Chapter 3, Fig. 2A) and maximum values, and 
the daily AUC of serum BHBA concentration (Chapter 3, Table 3) showed linear dose × 
treatment interactions, demonstrating a decrease in BHBA concentration with increasing dose 
of glucose. Glucose is known for its direct and indirect antiketogenic effects (TREACHER et 





acids to the liver by stimulating lipogenesis and inhibiting lipolysis in adipose tissue and (2) 
eliciting metabolic alterations within the liver that alter enzyme activities and availability of 
substrates that are involved in hepatic ketogenesis (TREACHER et al. 1976). With regard to 
the liver, such effect on the activity of enzymes involved in hepatic fatty acid oxidation was 
evident in the present experiment from the decreased CPT activity as will be discussed in next 
section. Collectively, the depressive effect of GI on serum NEFA and BHBA concentrations 
indicates that the anabolism analysed in Section 6.6 was, to a significant part, due to shifts in 
lipid metabolism from energy generating pathways to anabolic pathways. 
 
6.8 Hepatic but Not Skeletal Muscle CPT Activity Is Sensitive to the Changes in Energy    
Balance Status  
The hepatic fatty acid oxidation process is likely involved in the adaptation of the dairy cows 
to changes in energy supply. This is evident from previous observations that CPT activity 
increased or tended to increase during periods of NEB (DANN and DRACKLEY 2005; 
DOUGLAS et al. 2006) and decreased with a high-energy diet (AIELLO et al. 1984). 
Consistent with these results, gradual increase in glucose availability, brought by intravenous 
GI in the present experiment, revealed a continuous decrease in hepatic CPT activity with 
increasing GI (Chapter 5, Table 1). The mechanism by which hepatic CPT activity was 
decreased was not investigated in this study. However, the regulation of CPT-1 activity is 
thought to occur predominantly via changes in cytoplasmic malonyl-CoA concentrations 
(KERNER and HOPPEL 2000). A previous report by ZAMMIT (1999) suggested that insulin 
was able to increase the malonyl-CoA sensitivity of CPT-1 via a modification of the 
mitochondrial membrane fluidity. In addition, CPT activity was lower in mitochondria 
isolated from sheep hepatocytes preincubated with insulin (CHOW and JESSE 1992). 
Therefore, the elevation in serum insulin level may provide one possible explanation to the 
cause of glucose-induced depression of hepatic CPT activity. Additionally, the numerical 
decreases in the hepatic mRNA expression of both CPT-1A (by 28 %) and CPT-2 (by 42%), 
which were in the same range like the observed decrease in enzyme activity (by 35%) 
between d 0 and d 24 likely also contributed to the decreased hepatic CPT activity via 
transcriptional regulation. 
 
 Maintaining optimal hepatic CPT function during the dry period could be critical for cows 
to make a smooth transition into the heavy milk production period. As hepatic CPT activity 





balance during the dry period would negatively affect hepatic LCFA oxidation, which could 
be relevant for postpartum metabolic disturbances. In line with that, a beneficial effect of 
prepartum feed restriction on postpartum lipid metabolism through increased CPT activity or 
mRNA levels has been described recently (DOUGLAS et al. 2006; LOOR et al. 2006). 
Enhancing hepatic capacity for β-oxidation by increased CPT activity will direct LCFA 
toward mitochondrial oxidation rather than esterification, thereby leading to less 
accumulation of lipid and TAG in the liver (DOUGLAS et al. 2006). 
  
The literature screening in the present work revealed no information about the changes in 
skeletal muscle CPT activity relative to the energy balance in dairy cows. However, this is an 
important issue since failure to upregulate CPT activity in muscle with increasing availability 
of NEFA during times of negative energy balance would promote the accumulation of 
intracellular lipids. It has been shown in other species that such accumulation of intracellular 
lipids leads to insulin resistance (KREBS and RODEN 2004) due to suppression of insulin 
signaling pathways (CAHOVÁ et al. 2007). An observation coming from the present study is 
that the regulatory effect of surplus glucose on hepatic CPT activity was not observed on 
skeletal muscle CPT, suggesting that muscle CPT activity maybe less sensitive to the changes 
in energy supply in lactating dairy cows. In contrast to the skeletal muscle which utilizes 
NEFA exclusively for its own energy metabolism, the liver clears NEFA from the systemic 
circulation in excess of its own demand and converts part of them to water-soluble ketone 
bodies (e.g. BHBA and acetoacetate) that can be used as energy substrates by other tissues. 
Thereby, hepatic fatty acid oxidation plays a key role not only for the control of blood NEFA 
levels but also for the provision of adequate amounts of ketone bodies to provide fuel to 
extrahepatic tissues. From a teleological point of view, it appears thus reasonable that hepatic 
fatty acid oxidation has a higher metabolic priority for regulation and requires larger plasticity 
compared to fatty acid oxidation in skeletal muscle. 
 
6.9 Adaptations Are Rapidly Reversible after Ceasing of Glucose Infusions Except for  
Those of Lipid Metabolism 
Apart from investigating the dose effects of glucose, another intention of the present study 
was to test how quick possible changes in intermediary metabolism can be reversed after 
withdrawing a non-physiologically high glucose load. The withdrawal part of the 
experimental model relates to the important question if energy overfeeding prepartum may 





hypoglycaemia due to insufficient gluconeogensis). Thus, the infusion dose was maintained at 
30% of the NEL requirement between d 24 and 28 (i.e. 4 d) before the post infusion samples 
were collected on d 32 (i.e. 4 d after the end of the infusion period).  
 
For parameters related to glucose intermediary metabolism, post-infusion samples showed 
that daily mean values of plasma glucose concentration in the GI group had returned to 
baseline values while daily mean values of serum insulin concentration remained slightly 
elevated compared with baseline values at d 0 (Chapter 3, Fig. 1). Additionally, blood glucose 
and insulin values from the blood samples collected every 2 d (Chapter 4, Fig 1), daily 
minimum and maximum values and AUC of plasma glucose and serum insulin (Chapter 3, 
Table 3) were not different between d 0 and d 32 in both groups. The decreases in RQUIKI 
values (Chapter 3, Fig. 1C), hepatic PC mRNA and FBPase activity (Chapter 4, Table 2) and 
the increases in the glycogen levels in liver and skeletal muscles of GI cows (Chapter 3, Fig 
3) were fully reversed and returned to pre-infusion values, indicating that glucose metabolism 
of dairy cattle is very robust with regard to changes in glucose supply. In this study, excess 
glucose supply and sudden glucose withdrawal were both surprisingly well tolerated. 
 
For parameters related to lipid intermediary metabolism, post-infusion values were lower 
in the GI group for serum NEFA concentration (2-d samples; Chapter 4, Fig 2C), minimum 
daily concentrations of serum BHBA and NEFA, and daily AUC for serum BHBA (Chapter 
3, Table 3). Serum BHBA levels were also lower than initial values at 1600 h and 0400 h on d 
32 (Chapter 5, Fig. 3). Moreover, the depression in hepatic CPT activity persisted until four 
days after the end of the infusion period (Chapter 5, Table 1). Lower post-infusion values of 
serum BHBA and hepatic CPT activity in GI cows commonly suggest that hepatic capacity 
for LCFA oxidation was lower compared to d 0. It seems, therefore, that GI cows were less 
dependent on their lipid body stores as a source of energy after ceasing GI. This could, in 
part, be related to the availability of glycogen as an additional glucose source during the post-
infusion period in the GI group. 
 
Taken together, the beneficial effect of surplus glucose on lactation performance is 
negligible in midlactating dairy cows. Most of the infused glucose was used to increase the 
body reserves of glycogen and fat. Cows adapted well to nutritionally relevant increases of 
glucose supply by making adjustments in the intermediary metabolism to coordinate the 





utilization and storage by peripheral tissues and as a consequence, 2) the diversion of protein 
and lipid from energy-generating pathways into anabolic pathways. However, non-
nutritionally relevant GI doses were associated with alterations in the peripheral insulin 
sensitivity and in the catalytic capacity of some hepatic gluconeogenesis enzymes (i.e. PC, 
FBPase). In general, glucose homeastasis of midlactation dairy cows proofed to be very 
robust to both gradual increases in glucose supply and sudden withdrawal thereof. If the 
results of the present study were transferable to the postpartum cow, this may suggest that 
disturbances of glucose homestasis are more likely a secondary event in metabolic 
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Knowledge on the precise effects of surplus glucose supply in dairy cows is limited by the 
lack of information on how intermediary metabolism adapts at different levels of glucose 
availability. Therefore, a gradual increase of glucose supply via intravenous glucose infusion 
was used in the present study to test the dose effect of surplus provision of glucose on the 
metabolic status and milk production of dairy cows. Furthermore, the effects of increasing 
levels of surplus glucose on mRNA expressions and activities of rate-limiting enzymes 
involved in hepatic gluconeogenesis were investigated. Based on a previous finding that a 
positive energy balance may decrease hepatic carnitine palmitoyltransferase (CPT) enzyme 
activity, it was also of interest whether skeletal muscle CPT activity is downregulated in a 
similar manner during positive energy balance.  
 
Twelve midlactating Holstein-Friesian dairy cows were continuously infused over a 28-d 
experimental period with either saline (SI group, six cows) or 40% glucose solutions (GI 
group, six cows). The infusion dose was calculated as a percentage of the daily energy (NEL) 
requirements by the animal, starting at 0% on d 0 and increasing gradually by 1.25%/d until a 
maximum dose of 30% was reached by d 24. Dose was then maintained at 30% NEL 
requirement for 5 d. No infusions were made between d 29-32. Liver and skeletal muscle 
biopsies were taken on d 0, 8, 16, 24, and 32. Body weight (BW) and back fat thickness 
(BFT) were recorded on biopsies days. Blood samples were taken every 2 d. In addition, 
blood samples over 24 h (6-h intervals) were taken the days before each biopsy. Milk and 





BW and BFT increased linearly with increasing glucose dose for GI cows. No differences 
were observed in the dry matter intake, milk energy output, and energy corrected milk yield 
between groups. However, milk protein percentage and yield increased linearly in the GI 
group. Only occasional increases in blood glucose and insulin concentrations were observed 
in blood samples taken at 1000 h every 2 d. However, during infusion dose of 30% NEL 
requirements on d 24, GI cows developed postprandial hyperglycemia associated with 
hyperinsulinemia, coinciding with glucosuria. The revised quantitative insulin sensitivity 
check index (RQUIKI) indicated linear development of insulin resistance for the GI 
treatment. GI decreased serum concentrations of beta-hydroxybutyrate (BHBA) and blood 
urea nitrogen and tended to decrease the serum concentration of non-esterified fatty acids 
(NEFA). Liver glycogen content increased, while glycogen content in skeletal muscle only 
tended to increase by GI. No significant changes were observed in the activities and relative 
mRNA expression levels of hepatic phosphoenolpyruvate carboxykinase and glucose 6-
phospatase. The activity of fructose 1,6-bisphosphatase (FBPase) and relative mRNA 
expression levels of pyruvate carboxylase (PC) were decreased in the GI group but only 
during the high dose of glucose infusion. Hepatic CPT activity decreased with GI and 
remained decreased on d 32. The hepatic expression levels of CPT-1A and CPT-2 mRNA 
were not significantly altered but tended to reflect the changes in enzyme activity. No effect 
of glucose infusion was observed on skeletal muscle CPT activity. The aforementioned 
adaptations were reversed four days after the end of glucose infusions except for those of BW, 
BFT, and lipid metabolism (i.e. serum BHBA and NEFA concentrations, hepatic CPT 
activity). 
It is concluded that mid-lactation dairy cows on an energy-balanced diet direct 
intravenously infused glucose predominantly to body fat reserves but not to increased 
lactation performance. Cows rapidly adapted to increasing glucose supply but experienced 
dose-dependent development of insulin resistance corresponding with postprandial 
hyperglycemia/hyperinsulinemia and glucosuria at dosages equivalent to 30% NEL 
requirements. The catalytic capacity of key hepatic gluconeogenesis enzymes in mid-lactating 
dairy cows is not significantly affected by nutritionally relevant increases of glucose supply. 
Only very high dosages selectively suppress PC transcription and FBPase activity. Finally, it 
can be concluded that suppression of CPT activity by positive energy balance appears to be 
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Die genauen Effekte einer additiven Glukoseversorgung von Milchkühen können aufgrund 
fehlender Informationen bezüglich der Anpassung des Intermediärstoffwechsels an 
verschiedene Stufen der Glukoseversorgung derzeit nur schwer abgeschätzt werden. Deshalb 
wurden im Rahmen der vorliegenden Studie die Dosiseffekte einer langsam ansteigenden, 
intravenösen Glukoseinfusion auf den metabolischen Status und die Milchproduktion 
laktierender Kühe untersucht. Zusätzlich wurden die Effekte der verschiedenen Glukosedosen 
auf die mRNA-Expression und Aktivität von ratenlimitierenden Enzymen der 
Glukoneogenese gemessen. Aufgrund älterer Befunde, dass eine positive Energiebilanz die 
Aktivität der hepatischen Carnitin-Palmitoyltransferase (CPT) senken kann, war es weiterhin 
im Rahmen dieser Studie von Interesse, ob die CPT-Aktivität der Skelettmuskulatur in 
ähnlicher Weise durch eine positive Energiebilanz herunterreguliert wird. 
Zwölf Holstein-Friesian-Kühe in der Mitte der Laktation wurden über 28 Tage entweder 
mit 0,9%-iger NaCl-Lösung (SI-Gruppe) oder einer 40%-igen Glukoselösung (GI-Gruppe) 
intravenös infundiert. Die Infusionsdosis wurde als Prozentsatz des täglichen Energiebedarfes 
(NEL) errechnet. Die Infusion wurde beginnend mit 0% am d 0 langsam um 1.25%/d 
gesteigert bis am d 24 eine Maximaldosis von 30% erreicht war. Die Dosis von 30% NEL-
Bedarf wurde über 5 d gehalten. Keine Infusionen erfolgten zwischen d 29 - 32. Biopsien von 
Leber und Skelettmuskulatur wurden an d 0, 8, 16, 24, and 32 gewonnen. Die Entnahme von 
Blutproben erfolgte aller 2 d. Zusätzlich wurden Blutproben über 24 h (6-stündige Intervalle) 
jeweils am Tag vor den Biopsien genommen. An den Biopsie-Tagen wurden Körpermasse 





BW und BFT erhöhten sich linear mit ansteigenden Glukosedosen in der GI-Gruppe. 
Keine Unterschiede waren bezüglich der Trockensubstanzaufnahme, Milchenergieabgabe und 
energiekorrigierten Milchleistung zwischen den beiden Gruppen zu verzeichnen. Jedoch 
erhöhten sich Milchproteingehalt und -menge linear in der GI-Gruppe. Nur gelegentlich 
wurden bei GI-Kühen erhöhte Konzentrationen von Glukose und Insulin in jenen Blutproben 
gemessen, die in zweitägigen Abständen um jeweils 10:00 Uhr gewonnen wurden. 
Demgegenüber entwickelten die Kühe der GI-Gruppe eine postprandiale Hyperglykämie und 
Hyperinsulinämie während der Infusion von 30% NEL-Bedarf am d 24, was mit einer 
Glukosurie gekoppelt war. Der Revised Quantitative Insulin Sensitivity Check Index 
(RQUIKI) deutete auf die lineare Entwicklung einer Insulinresistenz bei GI-Behandlung hin. 
Die Glukoseinfusion erniedrigte die Serumkonzentrationen von β-Hydroxybutyrat (BHBA) 
sowie Harnstoff-N. Die Serumkonzentration der freien Fettsäuren tendierte ebenfalls zu einem 
Abfall. Der Leberglykogengehalt erhöhte sich, wohingegen der Glykogengehalt im 
Skelettmuskel nur tendenziell durch Glukoseinfusion erhöht war. Die Aktivität und relative 
mRNA-Expression der hepatischen Phosphoenolpyruvat-Carboxykinase und Glukose-6-
phospatase wurden durch die Glukoseinfusion nicht verändert. Die Aktivität der Fruktose-1,6-
bisphosphatase (FBPase) und die relative mRNA-Expression der Pyruvat-Carboxylase (PC) 
waren in der GI-Gruppe nur während der Infusion der höchsten Glukosedosis erniedrigt. Die 
Aktivität der hepatischen CPT fiel während der Glukoseinfusion ab, was von einem 
tendenziellen Abfall der mRNA-Expression der CPT-1A and CPT-2 begleitet war. Die CPT-
Aktivität im Skelettmuskel war unverändert. Alle erwähnten Glukoseeffekte waren nach 
Absetzen der Glukoseinfusion (d 32) reversibel mit Ausnahme von BW, BFT und Parametern 
des Lipidstoffwechsels (d.h. Serum-BHBA und -NEFA-Konzentrationen sowie hepatische 
CPT-Aktivität). 
Es kann der Schluss gezogen werden, dass intravenös infundierte Glukose bei Milchkühen 
in der Mitte der Laktation hauptsächlich zu erhöhtem Fettansatz, nicht jedoch zu erhöhter 
Milchleistung führt. Kühe passen sich schnell an die erhöhte Glukoseversorgung an, zeigen 
jedoch dosisabhängig die Entwicklung einer Insulinresistenz mit postprandialer 
Hyperglykämie/Hyperinsulinämie und Glukosurie. Die katalytische Kapazität von 
Schlüsselenzymen der hepatischen Glukoneogenese wird durch ernährungsphysiologisch 
relevante Glukosemengen nicht signifikant verändert. Erst sehr hohe Glukosedosen führen zu 
einer selektiven Suppression der PC-Transkription sowie der FBPase-Aktivität. Eine 
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